GlaxoSmithKline PLC's Paxil antidepressant doesn't cause birth defects or heart defects when used during pregnancy, a doctor testified for the company during a trial in Philadelphia, where Glaxo has major operations. Anthony Scialli, a doctor of obstetrics and gynecology at Georgetown University Medical Center, told jurors that 65 percent of birth defects have no known cause. Yesterday marked the start of Glaxo's defense in a trial over allegations Paxil caused birth defects in Lyam Kilker, 3. - Bloomberg News
http://www.philly.com/inquirer/business/20090930_Business_news_in_brief.html
Wednesday, 30 September 2009
uksurvivors : Message: Interesting post from Bob Fiddaman
uksurvivors : Message: Interesting post from Bob Fiddaman: "Interesting post from Bob Fiddaman
Cervarix Vaccine: ' Unlikely Cause of Death'
Well, it would appear that GlaxoSmithKline's Cervarix vaccine was not the cause of 14 year old Natalie Morton's death, at least that are the reports coming from the mainstream media. It's all very confusing - one minute Coventry health officials are suspending the immunisation programme, the next they are announcing that they are not? Even more strange are the reports that the programme has been halted in other parts of the UK such as Knowsley, Halton and St Helens [Liverpool Daily Post] - Also, the Wales Online website claims that the batch used to immunise Natalie Morton and her school friends had been withdrawn from use in Wales?"
Cervarix Vaccine: ' Unlikely Cause of Death'
Well, it would appear that GlaxoSmithKline's Cervarix vaccine was not the cause of 14 year old Natalie Morton's death, at least that are the reports coming from the mainstream media. It's all very confusing - one minute Coventry health officials are suspending the immunisation programme, the next they are announcing that they are not? Even more strange are the reports that the programme has been halted in other parts of the UK such as Knowsley, Halton and St Helens [Liverpool Daily Post] - Also, the Wales Online website claims that the batch used to immunise Natalie Morton and her school friends had been withdrawn from use in Wales?"
Tuesday, 29 September 2009
US Cervarix delay deals blow to GlaxoSmithKline - but NOTHING to do with UK death of 14 year old girl
US Cervarix delay deals blow to GlaxoSmithKline
US regulators have delayed their decision on whether to approve GlaxoSmithKline's cervical cancer vaccine Cervarix.
The ruling from the powerful US Food and Drug Administration had been expected yesterday but instead the body announced it needed more time to consider the application.
The FDA's renewed caution came just a day after the death of 14-year- old Coventry girl Natalie Morton who had been vaccinated with Cervarix.
Bombshell: The FDA delay over GSK's vaccine is not thought to be linked to the death of a 14-year-old British girl
There was no indication that the latest set back to winning US approval for the product had anything to do with the tragedy in the UK.
A spokesman for the drugs firm said: 'They (the FDA) have not asked for any further information following what happened in Coventry and if they did we would obviously be willing to share with them any information they requested as we would with UK authorities and any other countries. Clearly the most important thing right now is to ascertain what happened
Read more: http://www.dailymail.co.uk/money/article-1217022/US-Cervarix-delay-deals-blow-GlaxoSmithKline.html#ixzz0SXN8dBUo
US regulators have delayed their decision on whether to approve GlaxoSmithKline's cervical cancer vaccine Cervarix.
The ruling from the powerful US Food and Drug Administration had been expected yesterday but instead the body announced it needed more time to consider the application.
The FDA's renewed caution came just a day after the death of 14-year- old Coventry girl Natalie Morton who had been vaccinated with Cervarix.
Bombshell: The FDA delay over GSK's vaccine is not thought to be linked to the death of a 14-year-old British girl
There was no indication that the latest set back to winning US approval for the product had anything to do with the tragedy in the UK.
A spokesman for the drugs firm said: 'They (the FDA) have not asked for any further information following what happened in Coventry and if they did we would obviously be willing to share with them any information they requested as we would with UK authorities and any other countries. Clearly the most important thing right now is to ascertain what happened
Read more: http://www.dailymail.co.uk/money/article-1217022/US-Cervarix-delay-deals-blow-GlaxoSmithKline.html#ixzz0SXN8dBUo
Cervarix Natalie Morton had "serious underlying medical condition"
uksurvivors : Message: Cervarix Natalie Morton had "serious underlying medical condition",: "A girl who died shortly after being given a cervical cancer vaccine had a 'serious underlying medical condition', an NHS Trust has said.
NHS Coventry said the vaccination was 'most unlikely to have caused the death' of Natalie Morton, 14.
She was given the Cervarix jab at Coventry's Blue Coat School on Monday and fell ill a few hours later"
Earlier the government said a national cervical cancer immunisation programme should continue.
Dr Caron Grainger, joint director of public health for NHS Coventry and Coventry City Council, said the results of a preliminary post-mortem examination had "revealed a serious underlying medical condition which was likely to have caused death".
"We are awaiting further test results which will take some time," she said. "However indications are that it was most unlikely that the HPV vaccination was the cause of death."
The injection - part of a national immunisation programme - protects against the human papilloma virus (HPV), a sexually transmitted disease linked to most cervical cancers.
'Easy-going child'
The Department of Health has ordered the batch of vaccine to be quarantined as a precaution, but insists there is no reason to stop the programme.
Meanwhile, the vaccine manufacturer, GlaxoSmithKline, announced it was recalling the batch - AHPVA043BB - for testing.
Headteacher Dr Julie Roberts and the Bishop of Coventry on the death of Natalie Morton
The Department of Health said it was working with the NHS and regulatory bodies to thoroughly investigate Natalie Morton's case.
A department spokesman said: "No link can be made between the death and the vaccine until all the facts are known.
"Results of tests on the batch of vaccine will be announced as soon as they are known.
"The HPV vaccination programme can continue as planned - there is no reason for the campaign to be suspended or interrupted."
He added that minor delays may occur in the next day or so while some areas await fresh supplies of HPV vaccine to replace quarantined stock.
NHS Coventry has not suspended its HPV programme but has decided to reschedule catch-up clinics planned for Tuesday and Wednesday.
Adverse reactions to Cervarix
Total number of reactions reported between April 2008 and 23 September 2009
Q and A: Cervical cancer
Natalie's death has left schoolmates and staff shocked and saddened, headteacher Dr Julie Roberts said. She described Natalie as a "happy, easy-going child who worked hard".
A routine programme of vaccinating 12- and 13-year-old girls started in September 2008 using the Cervarix vaccine. A catch-up campaign is now under way for older girls.
It is thought about a million girls have already safely received the jab.
More than 1.4 million doses have been given out, of which there have been 4,657 suspected reactions reported, according to the Medicines and Healthcare Regulatory Agency.
There are more than 100 types of HPV but only 13 of them are known to cause cancer.
Cervarix, licensed for use in Europe since September 2007, protects against two strains of HPV that cause more than 70% of cervical cancer cases.
In the UK, about 3,000 women are diagnosed with cervical cancer every year and about 1,000 die from it.
Vaccination is not compulsory and consent is required before it is administered to the under-16s.
Parents or young people concerned about the safety of any vaccine are being advised to speak to their GP, visit www.nhs.uk or call NHS Direct on 0845 46 47.
NHS Coventry said the vaccination was 'most unlikely to have caused the death' of Natalie Morton, 14.
She was given the Cervarix jab at Coventry's Blue Coat School on Monday and fell ill a few hours later"
Earlier the government said a national cervical cancer immunisation programme should continue.
Dr Caron Grainger, joint director of public health for NHS Coventry and Coventry City Council, said the results of a preliminary post-mortem examination had "revealed a serious underlying medical condition which was likely to have caused death".
"We are awaiting further test results which will take some time," she said. "However indications are that it was most unlikely that the HPV vaccination was the cause of death."
The injection - part of a national immunisation programme - protects against the human papilloma virus (HPV), a sexually transmitted disease linked to most cervical cancers.
'Easy-going child'
The Department of Health has ordered the batch of vaccine to be quarantined as a precaution, but insists there is no reason to stop the programme.
Meanwhile, the vaccine manufacturer, GlaxoSmithKline, announced it was recalling the batch - AHPVA043BB - for testing.
Headteacher Dr Julie Roberts and the Bishop of Coventry on the death of Natalie Morton
The Department of Health said it was working with the NHS and regulatory bodies to thoroughly investigate Natalie Morton's case.
A department spokesman said: "No link can be made between the death and the vaccine until all the facts are known.
"Results of tests on the batch of vaccine will be announced as soon as they are known.
"The HPV vaccination programme can continue as planned - there is no reason for the campaign to be suspended or interrupted."
He added that minor delays may occur in the next day or so while some areas await fresh supplies of HPV vaccine to replace quarantined stock.
NHS Coventry has not suspended its HPV programme but has decided to reschedule catch-up clinics planned for Tuesday and Wednesday.
Adverse reactions to Cervarix
Total number of reactions reported between April 2008 and 23 September 2009
Q and A: Cervical cancer
Natalie's death has left schoolmates and staff shocked and saddened, headteacher Dr Julie Roberts said. She described Natalie as a "happy, easy-going child who worked hard".
A routine programme of vaccinating 12- and 13-year-old girls started in September 2008 using the Cervarix vaccine. A catch-up campaign is now under way for older girls.
It is thought about a million girls have already safely received the jab.
More than 1.4 million doses have been given out, of which there have been 4,657 suspected reactions reported, according to the Medicines and Healthcare Regulatory Agency.
There are more than 100 types of HPV but only 13 of them are known to cause cancer.
Cervarix, licensed for use in Europe since September 2007, protects against two strains of HPV that cause more than 70% of cervical cancer cases.
In the UK, about 3,000 women are diagnosed with cervical cancer every year and about 1,000 die from it.
Vaccination is not compulsory and consent is required before it is administered to the under-16s.
Parents or young people concerned about the safety of any vaccine are being advised to speak to their GP, visit www.nhs.uk or call NHS Direct on 0845 46 47.
uksurvivors : Message: David Healy transcripts removed from Baum Hedlund site
uksurvivors : Message: David Healy transcripts removed from Baum Hedlund site: "David Healy transcripts removed from Baum Hedlund site Message List
Reply Forward Delete Message #49097 of 49098 < Prev Next >
Message List
Message #49097 of 49098 < Prev
9/15/09 PM: David Healy, M.D. -- Direct Examination
9/16/09 AM: David Healy, M.D. -- Direct (continued)
9/16/09 PM: David Healy, M.D. -- Direct (continued); Cross Examination
9/17/09 AM: David Healy, M.D. -- Cross (continued); Redirect
9/17/09 PM: David Healy, M.D. -- Recross; Redirect
Plaintiffs Expert: Suzanne Parisian, M.D., former FDA employee
9/18/09 AM: Suzanne Parisian, M.D. -- Direct Examination
9/18/09 PM: Suzanne Parisian, M.D. -- Direct (continued)
Plaintiff's Expert: Shira Kramer, Ph.D., Epidemiologist
9/21/09 AM: Shira Kramer, Ph.D. -- Direct Examination
9/21/09 PM: Shira Kramer, Ph.D. -- Direct (continued); Cross Examination; Redirect
Reply Forward Delete Message #49097 of 49098 < Prev Next >
Message List
Message #49097 of 49098 < Prev
9/15/09 PM: David Healy, M.D. -- Direct Examination
9/16/09 AM: David Healy, M.D. -- Direct (continued)
9/16/09 PM: David Healy, M.D. -- Direct (continued); Cross Examination
9/17/09 AM: David Healy, M.D. -- Cross (continued); Redirect
9/17/09 PM: David Healy, M.D. -- Recross; Redirect
Plaintiffs Expert: Suzanne Parisian, M.D., former FDA employee
9/18/09 AM: Suzanne Parisian, M.D. -- Direct Examination
9/18/09 PM: Suzanne Parisian, M.D. -- Direct (continued)
Plaintiff's Expert: Shira Kramer, Ph.D., Epidemiologist
9/21/09 AM: Shira Kramer, Ph.D. -- Direct Examination
9/21/09 PM: Shira Kramer, Ph.D. -- Direct (continued); Cross Examination; Redirect
"Paxil Birth Defects Testimony Now Online" says Phil Dawdy of Furious Seasons. - Seems he's not up to speed !!
Paxil Birth Defects Testimony Now Online
By which I mean that Bob Fiddaman of Seroxat Sufferers fame has gotten pdfs of opening arguments and the testimony of psychiatrist David Healy and another plaintiff's expert witness and put them online right here. More will come later as the trial, which is taking place in Philadelphia, continues. This will include some never-seen-before documents regarding what GlaxoSmithKline knew and when it knew it about birth defects problems with Paxil.
The opening arguments--both sides--are well worth a read
By which I mean that Bob Fiddaman of Seroxat Sufferers fame has gotten pdfs of opening arguments and the testimony of psychiatrist David Healy and another plaintiff's expert witness and put them online right here. More will come later as the trial, which is taking place in Philadelphia, continues. This will include some never-seen-before documents regarding what GlaxoSmithKline knew and when it knew it about birth defects problems with Paxil.
The opening arguments--both sides--are well worth a read
Monday, 28 September 2009
Cervarix one dead, several classmates ill !!
Schoolgirl dies after being given cervical cancer jab
http://health.groups.yahoo.com/group/SSRI-Crusaders/message/34568
http://www.timesonline.co.uk/tol/life_and_style/health/article6852858.ece
A 14-year-old schoolgirl has died shortly after being given a vaccine against the virus that can cause cervical cancer as part of a national immunisation programme.
Serious side-effects are understood to have affected several classmates at a school in Coventry, The Times has learnt, which in at least one case have been fatal.
The schoolgirl is understood to have died in the last few hours, after being an injection of given Cervarix, which guards against the human papilloma virus (HPV), a sexually transmitted infection that causes up to 70 per cent of cervical cancer cases. It is believed to be the first death linked to the jab since a nationwide vaccination programme began in September.
In an official statement, Dr Caron Grainger, Joint Director of Public Health for NHS Coventry and the city's council, said: "A 14-year-old girl took ill at a school in Coventry and was taken to University Hospital in the city where she later sadly died. Our sympathies are with the girl's family and friends at this difficult time.
Related Links
•
"The incident happened shortly after the girl had received her HPV vaccine in the school. No link can be made between the death and the vaccine until all the facts are known and a post-mortem takes place. NHS Coventry has taken the proactive step to quarantine the batch of vaccine being used as a precautionary measure only, and has informed the regulatory authority. We are conducting an urgent and full investigation into the event surrounding this tragedy."
The health authority added: "Separately it has been brought to our attention that a small number of girls at the school had reported mild symptoms, such as dizziness and nausea. They have not been admitted to hospital."
The Health Protection Agency said it had been made aware of the situation but referred The Times to the Department of Health , which is understood to be preparing an official response.
The Medicines and Healthcare Regulatory Agency (MRHA) also said it had received enquiries about the safety of the Cervarix vaccine, which has been given to all schoolgirls aged 12 and over since September as part of a national campaign. By 2011 all girls under 18 will have been offered the vaccine.
Britain is the only country in the world to have selected Cervarix, made by GlaxoSmithKline, for a widespread vaccination programme, instead of Gardasil, a rival vaccine made by Merck.
Previously the jab has been associated with side-effects including nausea and dizziness, but not directly linked to any serious cases and by March the MHRA had received more than 1,500 reports of reactions to its use. But the Agency and the Department of Health said that was among more than 700,000 doses given to girls and that the vaccine was safe and had not been associated with severe side-effects.
GlaxoSmithKline was unable to comment on the latest case.
In a statement issued earlier this year, the Department of Health said: "The HPV vaccination programme prevents cervical cancer and will save the lives of up to an estimated 400 women each year. Both HPV vaccines have met the rigorous safety and efficacy standards required for licensing in Europe and elsewhere. It is irresponsible to raise fears over vaccine safety in the absence of scientific evidence that points to safety concerns.''
http://health.groups.yahoo.com/group/SSRI-Crusaders/message/34568
http://www.timesonline.co.uk/tol/life_and_style/health/article6852858.ece
A 14-year-old schoolgirl has died shortly after being given a vaccine against the virus that can cause cervical cancer as part of a national immunisation programme.
Serious side-effects are understood to have affected several classmates at a school in Coventry, The Times has learnt, which in at least one case have been fatal.
The schoolgirl is understood to have died in the last few hours, after being an injection of given Cervarix, which guards against the human papilloma virus (HPV), a sexually transmitted infection that causes up to 70 per cent of cervical cancer cases. It is believed to be the first death linked to the jab since a nationwide vaccination programme began in September.
In an official statement, Dr Caron Grainger, Joint Director of Public Health for NHS Coventry and the city's council, said: "A 14-year-old girl took ill at a school in Coventry and was taken to University Hospital in the city where she later sadly died. Our sympathies are with the girl's family and friends at this difficult time.
Related Links
•
"The incident happened shortly after the girl had received her HPV vaccine in the school. No link can be made between the death and the vaccine until all the facts are known and a post-mortem takes place. NHS Coventry has taken the proactive step to quarantine the batch of vaccine being used as a precautionary measure only, and has informed the regulatory authority. We are conducting an urgent and full investigation into the event surrounding this tragedy."
The health authority added: "Separately it has been brought to our attention that a small number of girls at the school had reported mild symptoms, such as dizziness and nausea. They have not been admitted to hospital."
The Health Protection Agency said it had been made aware of the situation but referred The Times to the Department of Health , which is understood to be preparing an official response.
The Medicines and Healthcare Regulatory Agency (MRHA) also said it had received enquiries about the safety of the Cervarix vaccine, which has been given to all schoolgirls aged 12 and over since September as part of a national campaign. By 2011 all girls under 18 will have been offered the vaccine.
Britain is the only country in the world to have selected Cervarix, made by GlaxoSmithKline, for a widespread vaccination programme, instead of Gardasil, a rival vaccine made by Merck.
Previously the jab has been associated with side-effects including nausea and dizziness, but not directly linked to any serious cases and by March the MHRA had received more than 1,500 reports of reactions to its use. But the Agency and the Department of Health said that was among more than 700,000 doses given to girls and that the vaccine was safe and had not been associated with severe side-effects.
GlaxoSmithKline was unable to comment on the latest case.
In a statement issued earlier this year, the Department of Health said: "The HPV vaccination programme prevents cervical cancer and will save the lives of up to an estimated 400 women each year. Both HPV vaccines have met the rigorous safety and efficacy standards required for licensing in Europe and elsewhere. It is irresponsible to raise fears over vaccine safety in the absence of scientific evidence that points to safety concerns.''
UK Schoolgirl dies after cancer jab
Schoolgirl dies after cancer jab
http://health.groups.yahoo.com/group/SSRI-Crusaders/message/34567
http://news.bbc.co.uk/1/hi/uk/8279656.stm
A 14-year-old girl has died after being given a cervical cancer jab as part of a national immunisation programme, but the exact cause of death is unknown.
The pupil took ill at a school in Coventry shortly after she received the Cervarix vaccine. She was taken to hospital, where she died later.
The batch of the vaccine used has been quarantined by the local NHS.
The vaccine targets a sexually transmitted disease, which is linked to most cervical cancers
http://health.groups.yahoo.com/group/SSRI-Crusaders/message/34567
http://news.bbc.co.uk/1/hi/uk/8279656.stm
A 14-year-old girl has died after being given a cervical cancer jab as part of a national immunisation programme, but the exact cause of death is unknown.
The pupil took ill at a school in Coventry shortly after she received the Cervarix vaccine. She was taken to hospital, where she died later.
The batch of the vaccine used has been quarantined by the local NHS.
The vaccine targets a sexually transmitted disease, which is linked to most cervical cancers
Man child Fiddaman's reaction to UKsurvivors post 48854, goes to show he doesn't give a damm
Re: Paxil evidence was blatent hearsay
http://groups.yahoo.com/group/uksurvivors/message/48859
It's Groundhog Day .... again!
Fid
http://groups.yahoo.com/group/uksurvivors/message/48859
It's Groundhog Day .... again!
Fid
If the baby's Mom hasn't taken Paxil / Seroxat Fiddy doesn't care!! What kind of representative is that to have on the MHRA PPE?
--- In uksurvivors@yahoogroups.com, "bob_fid2000" wrote:
>
> Judging by the goader's recent 'pro GSK' posts, one would assume that he is desperate for the current Paxil trial to be doomed to failure. Pretty sad considering all those babies that have been born with heart defects as a result of GSK's drug.
>
http://groups.yahoo.com/group/uksurvivors/message/48854
I will start by saying what I have repeatedly said when posting on this and other lists - I have no problem with anyone taking legal action and have never spoken out against the litigation.
It would appear from this post that although concern is expressed about "babies born with heart defects" - it's only babies affected by Seroxat / Paxil that seem to matter, when you consider what has already been posted in regard the Efexor heart defect baby deaths!! Now that's pretty sad too.
So what about the babies born with birth defects who's mothers were and are still taking one of the other drugs in the class – mothers blissfully unaware of the risk they are taking? And why is that?
Is it possibly due to the extreme adverse publicity afforded to the one particular drug - Seroxat?
Little things - like the much publicised Panorama Seroxat programs - that the Shelley Jofre's Coventry University Lecture Podcast clearly states were deliberately focused on the one drug – despite the production team and herself knowing the problems with SSRIs were a drug class phenomenon – Panorama actively chose to concentrate only on Seroxat? http://coventryuniversity.podbean.com/2007/11/01/one-woman-a-multinational-and-a-victory-shelley-jofre-panorama/
The publicity procured by the Seroxat litigation Lawyers Hugh James who liaised with Shelley Jofre and Panorama throughout the production of their first Seroxat program?
The publicity purchased by Hugh James and their PR company Good Relations – further generated by a few self seeking politicians like Paul Flynn who took the SSRI issue to parliament but only named Seroxat – and persist on their blogs to still do this - despite them commenting on an article about the SSRI drug class?
The biased and lazy journalism of the media and main stream press who latched onto - because of the Panorama programs and political interest - a quick fix, already sensationalized headline and used the name Seroxat as a marketing tool - despite their articles being about problems with the drug class?
The yellow cards published by MIND for Panorama - aimed at and issued to those taking Seroxat who contacted the show - that were accepted by the MHRA - that have further distorted statistics vital to establish all drug ADR issues?
The now misrepresented Yellow Card reports that NICE and the MHRA rely on and have to work with as available data and statistics, to assess all drugs efficacy and safety?
Here's the result of this publicity
http://tuesday1st.blogspot.com/
Seroxat prescriptions have fallen from 3.7 million in 2001 to 1.6 million in 2008
whilst total prescriptions for the drug class have increased from 14 million in 2001 to 24.3 million in 2008
Exclude Seroxat from the equation and total prescription for the SSSRI, SNRI drug class have risen from 10.3 million in 2001 to a 2008 total of 22.7 million
]
That's thousands – no - Millions of people who have - and are being denied the right to make an informed choice about treatment with the SSRI, SNRI drug class -
and Millions including unborn babies at risk.
The more recent publicity about birth defects and article by Dr David Healy was centred on the SSRI, SNRI drug class - but Seroxat has still been the most named drug in the media.
The whole contrived and generated Seroxat withdrawal furore has been a self perpetuating roller coaster and it's the patients on ALL drugs in the class that are the victims of it.
At patient level the publicity will have raised awareness of withdrawal problems with Seroxat – this will give rise to expectation, dread, even fear of having problems when coming off it;
A self fulfilling prophecy as this will compound and exaggerate any withdrawal symptoms however slight and make them appear worse; those affected will make more complaints to docs with the accompanying question "is it Seroxat?".
Docs, to a point, are guided by the findings of NICE and the MHRA, but also by their own opinions - probably influenced by the Seroxat publicity;
This will give a false raised awareness of problems with that particular drug and possibly the sense of a need for self protection and damage limitation, because the word litigation has been brought into the equation.
This will have resulted in them listening to and taking patient complaints of ADRs with Seroxat more seriously than patient complaints about other drugs in the class, looking for further serious possible ADRs and more stringent yellow card reporting.
My concern about the possible connection with the SSRI, SNRI drug class and birth defects goes back to before 2003/4, when I spent nearly a year helping one young woman get off Seroxat and alcohol because she wanted to have a second child.
Only to have her contact me in a panic in 2006 when her marriage and she had a wobble, her GP prescribed and she had started taking fluoxetine at the end of her first trimester.
Had her GP said Prozac she would have immediately recognised the drug and known it was an SSRI, although this would have been doubtful with other lesser publicised drugs in the class.
To those not involved with the litigation - this is of special concern with regard more serious side effects and ADRs like birth defects - because the medical profession are not looking for or associating them with the other drugs in the class - neither are patients.
To those involved with the litigation – of special concern is maintaining Seroxats single drug false notoriety to protect the Group, Seroxat Litigation Order: No 68: which shows that the whole litigation is dependant on the very flimsy `Defining Issue' that Seroxat is harder to get off than any other SSRI. http://www.hmcourts-service.gov.uk/cms/150_14671.htm
The litigation has been framed to make Seroxat appear the worse drug in the class which is giving the false impression that the other drugs in the class are safe –
as I said I'm not against anyone taking legal action or the litigation – I am against the harm it's causing millions of other people including Seroxat victims who have – to their cost - been swapped to other drugs in the class.
Tues
http://www.seroxatusergroup.org.UK/Documents/newsletter2.doc
Extract from Seroxat Newsletter-
"BBC Panorama is planning to broadcast a follow up to the `Secrets of Seroxat' documentary in May. Many of you who contacted the programme will have been asked by the producer to fill in a special version of the Yellow Card designed for Panorama by MIND. The Yellow Card system is used by GPs to report drug safety issues to the Medicine's Control Agency. If your GP has not already filled in a Yellow Card about Seroxat, please ask them to do so. see full document here"
Tuesday1st UK: SSRI / SNRI Antidepressant Statistical Politics.
>
> Judging by the goader's recent 'pro GSK' posts, one would assume that he is desperate for the current Paxil trial to be doomed to failure. Pretty sad considering all those babies that have been born with heart defects as a result of GSK's drug.
>
http://groups.yahoo.com/group/uksurvivors/message/48854
I will start by saying what I have repeatedly said when posting on this and other lists - I have no problem with anyone taking legal action and have never spoken out against the litigation.
It would appear from this post that although concern is expressed about "babies born with heart defects" - it's only babies affected by Seroxat / Paxil that seem to matter, when you consider what has already been posted in regard the Efexor heart defect baby deaths!! Now that's pretty sad too.
So what about the babies born with birth defects who's mothers were and are still taking one of the other drugs in the class – mothers blissfully unaware of the risk they are taking? And why is that?
Is it possibly due to the extreme adverse publicity afforded to the one particular drug - Seroxat?
Little things - like the much publicised Panorama Seroxat programs - that the Shelley Jofre's Coventry University Lecture Podcast clearly states were deliberately focused on the one drug – despite the production team and herself knowing the problems with SSRIs were a drug class phenomenon – Panorama actively chose to concentrate only on Seroxat? http://coventryuniversity.podbean.com/2007/11/01/one-woman-a-multinational-and-a-victory-shelley-jofre-panorama/
The publicity procured by the Seroxat litigation Lawyers Hugh James who liaised with Shelley Jofre and Panorama throughout the production of their first Seroxat program?
The publicity purchased by Hugh James and their PR company Good Relations – further generated by a few self seeking politicians like Paul Flynn who took the SSRI issue to parliament but only named Seroxat – and persist on their blogs to still do this - despite them commenting on an article about the SSRI drug class?
The biased and lazy journalism of the media and main stream press who latched onto - because of the Panorama programs and political interest - a quick fix, already sensationalized headline and used the name Seroxat as a marketing tool - despite their articles being about problems with the drug class?
The yellow cards published by MIND for Panorama - aimed at and issued to those taking Seroxat who contacted the show - that were accepted by the MHRA - that have further distorted statistics vital to establish all drug ADR issues?
The now misrepresented Yellow Card reports that NICE and the MHRA rely on and have to work with as available data and statistics, to assess all drugs efficacy and safety?
Here's the result of this publicity
http://tuesday1st.blogspot.com/
Seroxat prescriptions have fallen from 3.7 million in 2001 to 1.6 million in 2008
whilst total prescriptions for the drug class have increased from 14 million in 2001 to 24.3 million in 2008
Exclude Seroxat from the equation and total prescription for the SSSRI, SNRI drug class have risen from 10.3 million in 2001 to a 2008 total of 22.7 million
]
That's thousands – no - Millions of people who have - and are being denied the right to make an informed choice about treatment with the SSRI, SNRI drug class -
and Millions including unborn babies at risk.
The more recent publicity about birth defects and article by Dr David Healy was centred on the SSRI, SNRI drug class - but Seroxat has still been the most named drug in the media.
The whole contrived and generated Seroxat withdrawal furore has been a self perpetuating roller coaster and it's the patients on ALL drugs in the class that are the victims of it.
At patient level the publicity will have raised awareness of withdrawal problems with Seroxat – this will give rise to expectation, dread, even fear of having problems when coming off it;
A self fulfilling prophecy as this will compound and exaggerate any withdrawal symptoms however slight and make them appear worse; those affected will make more complaints to docs with the accompanying question "is it Seroxat?".
Docs, to a point, are guided by the findings of NICE and the MHRA, but also by their own opinions - probably influenced by the Seroxat publicity;
This will give a false raised awareness of problems with that particular drug and possibly the sense of a need for self protection and damage limitation, because the word litigation has been brought into the equation.
This will have resulted in them listening to and taking patient complaints of ADRs with Seroxat more seriously than patient complaints about other drugs in the class, looking for further serious possible ADRs and more stringent yellow card reporting.
My concern about the possible connection with the SSRI, SNRI drug class and birth defects goes back to before 2003/4, when I spent nearly a year helping one young woman get off Seroxat and alcohol because she wanted to have a second child.
Only to have her contact me in a panic in 2006 when her marriage and she had a wobble, her GP prescribed and she had started taking fluoxetine at the end of her first trimester.
Had her GP said Prozac she would have immediately recognised the drug and known it was an SSRI, although this would have been doubtful with other lesser publicised drugs in the class.
To those not involved with the litigation - this is of special concern with regard more serious side effects and ADRs like birth defects - because the medical profession are not looking for or associating them with the other drugs in the class - neither are patients.
To those involved with the litigation – of special concern is maintaining Seroxats single drug false notoriety to protect the Group, Seroxat Litigation Order: No 68: which shows that the whole litigation is dependant on the very flimsy `Defining Issue' that Seroxat is harder to get off than any other SSRI. http://www.hmcourts-service.gov.uk/cms/150_14671.htm
The litigation has been framed to make Seroxat appear the worse drug in the class which is giving the false impression that the other drugs in the class are safe –
as I said I'm not against anyone taking legal action or the litigation – I am against the harm it's causing millions of other people including Seroxat victims who have – to their cost - been swapped to other drugs in the class.
Tues
http://www.seroxatusergroup.org.UK/Documents/newsletter2.doc
Extract from Seroxat Newsletter-
"BBC Panorama is planning to broadcast a follow up to the `Secrets of Seroxat' documentary in May. Many of you who contacted the programme will have been asked by the producer to fill in a special version of the Yellow Card designed for Panorama by MIND. The Yellow Card system is used by GPs to report drug safety issues to the Medicine's Control Agency. If your GP has not already filled in a Yellow Card about Seroxat, please ask them to do so. see full document here"
Tuesday1st UK: SSRI / SNRI Antidepressant Statistical Politics.
Standards at the BBC have sure gone into the tank - says Furious seasons, but so called journalist Phil Dawdy refuses to cover Jofre podcast scandal
Standards at the BBC have sure gone into the tank. I can't see where a bunch of half-baked Internet rumors should lead to a legitimate journalist pressing a public official about what pills they take. Unless there's something else going on that I don't know about. But it's basically no one's business I would think.
Standards at the BBC have sure gone into the tank. I can't see where a bunch of half-baked Internet rumors should lead to a legitimate journalist pressing a public official
Standards at the BBC have sure gone into the tank. I can't see where a bunch of half-baked Internet rumors should lead to a legitimate journalist pressing a public official about what pills they take. Unless there's something else going on that I don't know about. But it's basically no one's business I would think.
http://www.furiousseasons.com/
British PM Asked By BBC If He's Taking Anti-Depressants
Apparently the British blogosphere is nuttier than the American one, because rumors began circulating round the Net recently that Gordon Brown, the Prime Minister of Britain, was coming unhinged in private, had OCD and depression and was allegedly taking anti-depressants. The hubub on the issue became so great that an interviewer for the BBC pressed him on it during a radio show.
Here's the Guardian's account of what went on:
"Marr [of the BBC] said this morning: 'A lot of people in this country use prescription painkillers and pills to help them get through. Are you one of those people?'
"Brown replied: 'No.' And when Marr asked him about the issue again later in the interview, he said that he had already dealt with the question.
"The prime minister seemed to object to Marr raising the matter, saying this was 'the sort of question that is all too often entering the lexicon of British politics.'"
Standards at the BBC have sure gone into the tank. I can't see where a bunch of half-baked Internet rumors should lead to a legitimate journalist pressing a public official about what pills they take. Unless there's something else going on that I don't know about. But it's basically no one's business I would think.
It all kind of reminds of lefty bloggers painting a psychological profile of President George W. Bush a few years ago. One psychologist even wrote a book about the President and his alleged maladies. I did not like Bush 43 much at all, but this sort of thing is just out of hand and is wildly disrespectful of the office and I hope that right wing bloggers and others don't attempt to play DSM game with President Barack Obama.
http://www.furiousseasons.com/
British PM Asked By BBC If He's Taking Anti-Depressants
Apparently the British blogosphere is nuttier than the American one, because rumors began circulating round the Net recently that Gordon Brown, the Prime Minister of Britain, was coming unhinged in private, had OCD and depression and was allegedly taking anti-depressants. The hubub on the issue became so great that an interviewer for the BBC pressed him on it during a radio show.
Here's the Guardian's account of what went on:
"Marr [of the BBC] said this morning: 'A lot of people in this country use prescription painkillers and pills to help them get through. Are you one of those people?'
"Brown replied: 'No.' And when Marr asked him about the issue again later in the interview, he said that he had already dealt with the question.
"The prime minister seemed to object to Marr raising the matter, saying this was 'the sort of question that is all too often entering the lexicon of British politics.'"
Standards at the BBC have sure gone into the tank. I can't see where a bunch of half-baked Internet rumors should lead to a legitimate journalist pressing a public official about what pills they take. Unless there's something else going on that I don't know about. But it's basically no one's business I would think.
It all kind of reminds of lefty bloggers painting a psychological profile of President George W. Bush a few years ago. One psychologist even wrote a book about the President and his alleged maladies. I did not like Bush 43 much at all, but this sort of thing is just out of hand and is wildly disrespectful of the office and I hope that right wing bloggers and others don't attempt to play DSM game with President Barack Obama.
Goodbye dear Seroxat, Hello withdrawal hell © BOB FIDDAMAN
Goodbye dear Seroxat
Hello withdrawal hell
Who will feel the wrath of me
underneath this angry spell?
Hello withdrawal hell
Who will feel the wrath of me
underneath this angry spell?
Sunday, 27 September 2009
Time to spread your wealth out make ammends to us poor souls © BOB FIDDAMAN
"Time to spread your wealth out
make ammends to us poor souls
whose lives have been shattered,
whose heads are full of holes.
© BOB FIDDAMAN
Paxil trial expert witness Dr Sloot believes - "fluoxetine, citalopram and venlafaxine suggest teratogenic potential"
uksurvivors : Message: fluoxetine, citalopram and venlafaxine suggest teratogenic potential: "fluoxetine, citalopram and venlafaxine suggest teratogenic potential
http://groups.yahoo.com/group/uksurvivors/message/49002
In vitro, paroxetine and the positive control retinol were the only compounds identified as a clear teratogen, but developmental morphological indicators suggestive of a teratogenic potential were observed for most other MRUIs, including fluoxetine, citalopram and venlafaxine.
so says Dr Sloot !!"
http://groups.yahoo.com/group/uksurvivors/message/49002
In vitro, paroxetine and the positive control retinol were the only compounds identified as a clear teratogen, but developmental morphological indicators suggestive of a teratogenic potential were observed for most other MRUIs, including fluoxetine, citalopram and venlafaxine.
so says Dr Sloot !!"
uksurvivors : Message: reproduction toxicology of 12 monoaminergic reuptake inhibitors - Dr Sloot
uksurvivors : Message: reproduction toxicology of 12 monoaminergic reuptake inhibitors - Dr Sloot: "In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: possible mechanisms of infrequent cardiovascular anomalies.
http://www.ncbi.nlm.nih.gov/pubmed/19383541
Sloot WN, Bowden HC, Yih TD.
Schering-Plough, NV Organon, Dept of Toxicology and Drug Disposition, P.O. Box 20, 5340 BH Oss, The Netherlands. willem.sloot@..."
The rat Whole Embryo Culture (WEC) has been used to predict the potential teratogenicity of 12 selective/mixed monoaminergic reuptake inhibitors (MRUI). WEC results were compared with in vivo animal and human epidemiological teratogenicity data. In vitro, paroxetine and the positive control retinol were the only compounds identified as a clear teratogen, but developmental morphological indicators suggestive of a teratogenic potential were observed for most other MRUIs, including fluoxetine, citalopram and venlafaxine. No clear evidence of teratogenic potential was observed for three compounds, however, all compounds assessed showed a dose-dependent general embryotoxicity. In vivo testing of nine MRUIs for teratogenicity was limited by maternal toxicity (e.g. anorexia) without showing overt embryotoxicity (e.g. implantation loss). Next to complete absence, the cardiovascular (CV) anomalies observed (mostly) in rabbits ranged from a low incidence (e.g. above historical background of 0.35%) to a clear incidence (mean 4.1%). It is suggested that observed specific malformations in vitro (e.g. branchial bars deformed, displaced or additional otic system), not noted in any (historical) controls, may be early ontogenetic indicators for infrequent CV-anomalies observed in vivo. Despite the low incidence of anomalies in vitro or in vivo, they may yet be clinically relevant as in the case of paroxetine. Possible mechanisms are discussed, e.g. perturbed neural crest cell migration.
http://www.ncbi.nlm.nih.gov/pubmed/19383541
Sloot WN, Bowden HC, Yih TD.
Schering-Plough, NV Organon, Dept of Toxicology and Drug Disposition, P.O. Box 20, 5340 BH Oss, The Netherlands. willem.sloot@..."
The rat Whole Embryo Culture (WEC) has been used to predict the potential teratogenicity of 12 selective/mixed monoaminergic reuptake inhibitors (MRUI). WEC results were compared with in vivo animal and human epidemiological teratogenicity data. In vitro, paroxetine and the positive control retinol were the only compounds identified as a clear teratogen, but developmental morphological indicators suggestive of a teratogenic potential were observed for most other MRUIs, including fluoxetine, citalopram and venlafaxine. No clear evidence of teratogenic potential was observed for three compounds, however, all compounds assessed showed a dose-dependent general embryotoxicity. In vivo testing of nine MRUIs for teratogenicity was limited by maternal toxicity (e.g. anorexia) without showing overt embryotoxicity (e.g. implantation loss). Next to complete absence, the cardiovascular (CV) anomalies observed (mostly) in rabbits ranged from a low incidence (e.g. above historical background of 0.35%) to a clear incidence (mean 4.1%). It is suggested that observed specific malformations in vitro (e.g. branchial bars deformed, displaced or additional otic system), not noted in any (historical) controls, may be early ontogenetic indicators for infrequent CV-anomalies observed in vivo. Despite the low incidence of anomalies in vitro or in vivo, they may yet be clinically relevant as in the case of paroxetine. Possible mechanisms are discussed, e.g. perturbed neural crest cell migration.
Paxil [Seroxat] "more powerful a teratogen than cocaine"
uksurvivors : Message: Paxil [Seroxat] "more powerful a teratogen than cocaine": "Paxil [Seroxat] 'more powerful a teratogen than cocaine'"
Read Dr Sloot's findings regarding the safety of Paxil in pregnant mothers. You
can do an online research for Dr Sloot to find his credentials... or you can
listen to the ramblings of the man who lives in a boat.
http://fiddaman.blogspot.com/2009/09/paxil-seroxat-more-powerful-teratogen.html
or short url
http://alturl.com/o5mq
Read Dr Sloot's findings regarding the safety of Paxil in pregnant mothers. You
can do an online research for Dr Sloot to find his credentials... or you can
listen to the ramblings of the man who lives in a boat.
http://fiddaman.blogspot.com/2009/09/paxil-seroxat-more-powerful-teratogen.html
or short url
http://alturl.com/o5mq
Saturday, 26 September 2009
HUMAN SACRIFICE - © BOB FIDDAMAN
HUMAN SACRIFICE © BOB FIDDAMAN
40 Mgs of Seroxat
to keep me safe from harm.
These drugs are not addictive
say's the suited man with charm.
They didn't warn of feelings
that swim inside my head.
feelings of hate, anger and jealousy
and wishing I was dead.
The secrets of Seroxat
hidden from us all.
To line the pockets of the rich men
while those around all fall.
Thank you Mr Executive man
and Pharmaceutrical Industry.
Thanks for all those lies & cover - ups
and what you've done to me.
Time to spread your wealth out
make ammends to us poor souls
whose lives have been shattered,
whose heads are full of holes.
Goodbye dear Seroxat
Hello withdrawal hell
Who will feel the wrath of me
underneath this angry spell?
Thank God, I'm not the only one
whose head cries out in pain.
While the bastards at GSK
drown in financial gain.
© BOB FIDDAMAN
http://www.postpoems.com/members/ballbreaker375
40 Mgs of Seroxat
to keep me safe from harm.
These drugs are not addictive
say's the suited man with charm.
They didn't warn of feelings
that swim inside my head.
feelings of hate, anger and jealousy
and wishing I was dead.
The secrets of Seroxat
hidden from us all.
To line the pockets of the rich men
while those around all fall.
Thank you Mr Executive man
and Pharmaceutrical Industry.
Thanks for all those lies & cover - ups
and what you've done to me.
Time to spread your wealth out
make ammends to us poor souls
whose lives have been shattered,
whose heads are full of holes.
Goodbye dear Seroxat
Hello withdrawal hell
Who will feel the wrath of me
underneath this angry spell?
Thank God, I'm not the only one
whose head cries out in pain.
While the bastards at GSK
drown in financial gain.
© BOB FIDDAMAN
http://www.postpoems.com/members/ballbreaker375
Cyndi is famous - Georgia USA checking out Scientology Witch-hunter Cyndi Cardell / Cornish Cynders
Host Name 68-116-72-209.static.mdfd.or.charter.com
IP Address 68.116.72.209
ISP CHARTER COMMUNICATIONS
Domain CHARTER.COM
City NEWNAN
Region GEORGIA
Country UNITED STATES
Returning Visits 0
Date Time WebPage
September 26, 2009 5:19:02 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: uksurvivors : Message: Fiddy is famous, says Scientology Witch-hunter Cynid Cardell / Cornish Cynders of UKsurvivors
http://bobfiddaman.blogspot.com/2009/09/uksurvivors-message-fiddy-is-famous.html
http://mail.google.com/mail/h/18fwgkaq4isfl/?v=c&th=123f6cc1708b3e59
IP Address 68.116.72.209
ISP CHARTER COMMUNICATIONS
Domain CHARTER.COM
City NEWNAN
Region GEORGIA
Country UNITED STATES
Returning Visits 0
Date Time WebPage
September 26, 2009 5:19:02 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: uksurvivors : Message: Fiddy is famous, says Scientology Witch-hunter Cynid Cardell / Cornish Cynders of UKsurvivors
http://bobfiddaman.blogspot.com/2009/09/uksurvivors-message-fiddy-is-famous.html
http://mail.google.com/mail/h/18fwgkaq4isfl/?v=c&th=123f6cc1708b3e59
Man child Bob Fiddaman throws a hissy fit & storms out the room - some would say they have seen it all before
http://groups.yahoo.com/group/uksurvivors/message/48998
Fiddaman said -
"What a complete prat you are.
Stick your fingers in your ears and go NA NA NA NA NA
You cannot handle the truth, that is your problem.
Fid"
Fiddaman said -
"What a complete prat you are.
Stick your fingers in your ears and go NA NA NA NA NA
You cannot handle the truth, that is your problem.
Fid"
Fiddaman reveals type of "sensationalism & scaremongering typically used by the Seroxat campaingners throught this saga"
So now we know ...............that Bob has no idea why those particular rats, in that particular study, died.
His eventual reply, after many reminders by me, clearly reveals the trype of sensationalism & scaremongering typically used by the Seroxat campaingners throught this saga.
http://groups.yahoo.com/group/uksurvivors/message/48997
Jeremy
His eventual reply, after many reminders by me, clearly reveals the trype of sensationalism & scaremongering typically used by the Seroxat campaingners throught this saga.
http://groups.yahoo.com/group/uksurvivors/message/48997
Jeremy
Blustering Fiddaman reply -"Let's say, we cannot be sure what caused the deaths in the rats,.."
Let's say, we cannot be sure what caused the deaths in the rats, let's say that
data, destroyed by a third party [according to GSK] would show us the possible
cause of death. Let's say that you, your daughter or your girlfriend was armed
with this knowledge before taking Seroxat. Would you be happy for your pregnant
daughter or girlfriend to take Seroxat?
Remember, the rat studies were not directed by GSK, in fact it was one of GSK's
scientists that discovered in the 1980's that the rat studies suggested Paxil
"could be" a cause of birth defects. Glaxo refused for almost 20 years to do
studies on why the young rats died. Why?
Do your homework and check out GSK's own 1998 internal review, you will see that
officials found "an alarmingly high number" of birth-defect reports with Seroxat
yet the report was never turned over to the FDA. Why?
Judging by your defence and obvious support of GSK, one would assume that you
would be prepared to stand by and let your pregnant daughter or girlfriend
administer Seroxat, am I right?
If the rat studies are so 'unimportant' - why hide them?
Something for you to ponder Jeremy before your next cut and paste job on here.
Fid
http://groups.yahoo.com/group/uksurvivors/message/48996
data, destroyed by a third party [according to GSK] would show us the possible
cause of death. Let's say that you, your daughter or your girlfriend was armed
with this knowledge before taking Seroxat. Would you be happy for your pregnant
daughter or girlfriend to take Seroxat?
Remember, the rat studies were not directed by GSK, in fact it was one of GSK's
scientists that discovered in the 1980's that the rat studies suggested Paxil
"could be" a cause of birth defects. Glaxo refused for almost 20 years to do
studies on why the young rats died. Why?
Do your homework and check out GSK's own 1998 internal review, you will see that
officials found "an alarmingly high number" of birth-defect reports with Seroxat
yet the report was never turned over to the FDA. Why?
Judging by your defence and obvious support of GSK, one would assume that you
would be prepared to stand by and let your pregnant daughter or girlfriend
administer Seroxat, am I right?
If the rat studies are so 'unimportant' - why hide them?
Something for you to ponder Jeremy before your next cut and paste job on here.
Fid
http://groups.yahoo.com/group/uksurvivors/message/48996
Seroxat rat studies - Fiddaman put on the spot in UKsurvivors
Re: SSRI cause Scary Mary
--- In uksurvivors@yahoogroups.com, "bob_fid2000"
>
> Would you allow your pregnant daughter or girlfriend to take Seroxat?
>
as I asked earlier (but received no answer) so I will ask it again .........what was the cause of the rat pup death Bob?
To which I will add, what is the relationship between the dose (i.e 15mgs or indeed 50 mgs Paxil) given to the rats in mgs per kg live body weight .............when the dose given to humans is typically 20 mgs. Surely humans have a much higher weight!
So yes Begonia it is Scary Mary, it was designed to be Scary because it was just sensationalism.
Besides just ask yourself how many human babies have died by day 4 when their mothers had ingested Seroxat whilst pregnant? ..............answers please Bob.
In writing this I'm not defending Seroxat or any other antidepressant, but as readers here we have a right to know, since Bob raised the point in the first place, what was dose per kg rat live body weight, how does that compare with dose per kg human body weight, what was the cause of death?
Jeremy
http://groups.yahoo.com/group/uksurvivors/message/48995
--- In uksurvivors@yahoogroups.com, "bob_fid2000"
>
> Would you allow your pregnant daughter or girlfriend to take Seroxat?
>
as I asked earlier (but received no answer) so I will ask it again .........what was the cause of the rat pup death Bob?
To which I will add, what is the relationship between the dose (i.e 15mgs or indeed 50 mgs Paxil) given to the rats in mgs per kg live body weight .............when the dose given to humans is typically 20 mgs. Surely humans have a much higher weight!
So yes Begonia it is Scary Mary, it was designed to be Scary because it was just sensationalism.
Besides just ask yourself how many human babies have died by day 4 when their mothers had ingested Seroxat whilst pregnant? ..............answers please Bob.
In writing this I'm not defending Seroxat or any other antidepressant, but as readers here we have a right to know, since Bob raised the point in the first place, what was dose per kg rat live body weight, how does that compare with dose per kg human body weight, what was the cause of death?
Jeremy
http://groups.yahoo.com/group/uksurvivors/message/48995
Friday, 25 September 2009
Fiddy is Famous - well he is to Eli Lilly
Host Name us_proxy_indy.xh1.lilly.com
IP Address 40.0.40.10
ISP ELI LILLY AND COMPANY
Domain LILLY.COM
City INDIANAPOLIS
Region INDIANA
Country UNITED STATES
Returning Visits
Date Time WebPage
September 25, 2009 6:19:14 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://74.125.93.132/search?q=cache:taDu6ZzahiEJ:bobfiddaman.blogspot.com/ note from Mr Fiddaman%27s self report of your meeting that he put forward the names of several people to you including a certainJanne Larsson&cd=1&hl=en&ct=clnk&gl=us
http://www.google.com/search?hl=en&safe=active&q=note from Mr Fiddaman%27s self report of your meeting that he put forward the names of several people to you including a certainJan ne Larsson &aq=f&oq=&aqi=
September 25, 2009 6:18:32 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Seroxat/Paxil lawyer - Karen Barth Menzies Baum Hedlund partner
http://74.125.93.132/search?q=cache:di4PD1SZnL0J:bobfiddaman.blogspot.com/2009/08/ab out-karen-barth-menzies-baum-hedlund.html /search%3Fhl%3Den%26safe%3Dactive%26q%3D%2Bsite:bobfiddama n.blogspot.com%2BSEROXAT%2BSUFFERERS%2BSTAND%2BUP%2BAND%2BBE%2BCOUNTED%
http://www.google.com/search?hl=en&safe=active&q=SEROXAT SUFFERERS STAND UP AND BE COUNTED perviously published FOI ...&aq=f&oq=&aqi=
September 25, 2009 6:18:20 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Christopher Pittman - New trial hearing over for SC man in Zoloft case (Lustral/Sertraline)
http://74.125.93.132/search?q=cache:SJ9Xp9_n_QoJ:bobfiddaman.blogspot.com/2009/08/ch ristopher-pittman-new-trial-hearing.html /search%3Fhl%3Den%26safe%3Dactive%26q%3D%2Bsite:bobfiddaman .blogspot.com%2BSEROXAT%2BSUFFERERS%2BSTAND%2BUP%2BAND%2BBE%2BCOUNTED%2
http://www.google.com/search?hl=en&safe=active&q=SEROXAT SUFFERERS STAND UP AND BE COUNTED perviously published FOI ...&aq=f&oq=&aqi=
September 25, 2009 6:17:04 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://74.125.93.132/search?q=cache:taDu6ZzahiEJ:bobfiddaman.blogspot.com/ SEROXAT S UFFERERS STAND UP AND BE COUNTED perviously published FOI ...&cd=1&hl=en&ct=clnk&gl=us
http://www.google.com/search?hl=en&safe=active&q=SEROXAT SUFFERERS STAND UP AND BE COUNTED perviously published FOI ...&aq=f&oq=&aqi=
IP Address 40.0.40.10
ISP ELI LILLY AND COMPANY
Domain LILLY.COM
City INDIANAPOLIS
Region INDIANA
Country UNITED STATES
Returning Visits
Date Time WebPage
September 25, 2009 6:19:14 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://74.125.93.132/search?q=cache:taDu6ZzahiEJ:bobfiddaman.blogspot.com/ note from Mr Fiddaman%27s self report of your meeting that he put forward the names of several people to you including a certainJanne Larsson&cd=1&hl=en&ct=clnk&gl=us
http://www.google.com/search?hl=en&safe=active&q=note from Mr Fiddaman%27s self report of your meeting that he put forward the names of several people to you including a certainJan ne Larsson &aq=f&oq=&aqi=
September 25, 2009 6:18:32 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Seroxat/Paxil lawyer - Karen Barth Menzies Baum Hedlund partner
http://74.125.93.132/search?q=cache:di4PD1SZnL0J:bobfiddaman.blogspot.com/2009/08/ab out-karen-barth-menzies-baum-hedlund.html /search%3Fhl%3Den%26safe%3Dactive%26q%3D%2Bsite:bobfiddama n.blogspot.com%2BSEROXAT%2BSUFFERERS%2BSTAND%2BUP%2BAND%2BBE%2BCOUNTED%
http://www.google.com/search?hl=en&safe=active&q=SEROXAT SUFFERERS STAND UP AND BE COUNTED perviously published FOI ...&aq=f&oq=&aqi=
September 25, 2009 6:18:20 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Christopher Pittman - New trial hearing over for SC man in Zoloft case (Lustral/Sertraline)
http://74.125.93.132/search?q=cache:SJ9Xp9_n_QoJ:bobfiddaman.blogspot.com/2009/08/ch ristopher-pittman-new-trial-hearing.html /search%3Fhl%3Den%26safe%3Dactive%26q%3D%2Bsite:bobfiddaman .blogspot.com%2BSEROXAT%2BSUFFERERS%2BSTAND%2BUP%2BAND%2BBE%2BCOUNTED%2
http://www.google.com/search?hl=en&safe=active&q=SEROXAT SUFFERERS STAND UP AND BE COUNTED perviously published FOI ...&aq=f&oq=&aqi=
September 25, 2009 6:17:04 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://74.125.93.132/search?q=cache:taDu6ZzahiEJ:bobfiddaman.blogspot.com/ SEROXAT S UFFERERS STAND UP AND BE COUNTED perviously published FOI ...&cd=1&hl=en&ct=clnk&gl=us
http://www.google.com/search?hl=en&safe=active&q=SEROXAT SUFFERERS STAND UP AND BE COUNTED perviously published FOI ...&aq=f&oq=&aqi=
University of Bristol interest in Seroxat legal action
Visitor Information: s244-021.nomadic.bris.ac.uk (THE UNIVERSITY OF BRISTOL) [Label Visitor]
Location: BRISTOL, ENGLAND, UNITED KINGDOM (BRIS.AC.UK)
Last Visit Time: September 25, 2009 9:14:25 AM Length of this Visit:
Page Viewed This Visit: 5 Returning Visits: 0
Entry Page: http://bobfiddaman.blogspot.com/
Exit Page: http://bobfiddaman.blogspot.com/
Referrer: http://www.google.com/search?client=safari&rls=en-us&q=seroxat legal action&ie=UTF- 8&oe=UTF-8
Location: BRISTOL, ENGLAND, UNITED KINGDOM (BRIS.AC.UK)
Last Visit Time: September 25, 2009 9:14:25 AM Length of this Visit:
Page Viewed This Visit: 5 Returning Visits: 0
Entry Page: http://bobfiddaman.blogspot.com/
Exit Page: http://bobfiddaman.blogspot.com/
Referrer: http://www.google.com/search?client=safari&rls=en-us&q=seroxat legal action&ie=UTF- 8&oe=UTF-8
Eli Lilly so interested in Fiddaman they stayed for 23 hours and 41 minutes
Visitor Information: us_proxy_indy.xh1.lilly.com (ELI LILLY AND COMPANY) [Label Visitor]
Location: INDIANAPOLIS, INDIANA, UNITED STATES (LILLY.COM)
Last Visit Time: September 25, 2009 12:57:51 PM Length of this Visit: 23 hours and 41 minutes
Page Viewed This Visit: Returning Visits:
Entry Page: http://bobfiddaman.blogspot.com/2009/09/eli-lilly-interested-in-how-fiddaman.html
Exit Page: http://74.125.93.132/search?q=cache:gdqUlmW0518J:bobfiddaman.blogspot.com/2009/09/e li-lilly-interested-in-how-fiddaman.html Eli Lilly interested in how Fiddaman tried to infiltrate Sc ientology journalist Janne Larsson into the MHRA&cd=2&hl=en&ct=clnk&gl=u
Referrer: No referrer
Location: INDIANAPOLIS, INDIANA, UNITED STATES (LILLY.COM)
Last Visit Time: September 25, 2009 12:57:51 PM Length of this Visit: 23 hours and 41 minutes
Page Viewed This Visit: Returning Visits:
Entry Page: http://bobfiddaman.blogspot.com/2009/09/eli-lilly-interested-in-how-fiddaman.html
Exit Page: http://74.125.93.132/search?q=cache:gdqUlmW0518J:bobfiddaman.blogspot.com/2009/09/e li-lilly-interested-in-how-fiddaman.html Eli Lilly interested in how Fiddaman tried to infiltrate Sc ientology journalist Janne Larsson into the MHRA&cd=2&hl=en&ct=clnk&gl=u
Referrer: No referrer
Lustral & Cipramil singled out but not Seroxat or Prozac
Editorials
Selective serotonin reuptake inhibitors and congenital malformations
The small risk of harm must be balanced against risk of suboptimalor no treatment
The first 150 words of the full text of this article appear below.
Major depressive disorder in women is most common during theirchildbearing years, and about 13% of women in the United Stateshave taken an antidepressant drug during pregnancy.1 2 In thepast 20 years, selective serotonin reuptake inhibitors (SSRIs)have become a mainstay of treatment in women with major depressivedisorder; however, concerns persist about safety for the developingfetus. This is counterbalanced by equally compelling concernsabout the consequences of undertreatment for mother and child.3
In the linked population based cohort study from Denmark (doi:10.1136/bmj.b3569),Pedersen and colleagues confirm a previously reported doublingof risk for septal heart defects after early exposure in pregnancyto SSRIs (odds ratio 1.99, 95% confidence interval 1.12 to 3.53).4However, in contrast to previous studies, redemptions of prescriptionsfor citalopram and sertraline, but not paroxetine or fluoxetine,were significantly associated with this group of heart defects.56 7 8 Furthermore, unlike two previous large case-control . . . [Full text of this article]
Christina Chambers, associate professor
1 Division of Dysmorphology and Teratology, Departments of Pediatrics and Family and Preventive Medicine, School of Medicine, University of California San Diego, 9500 Gilman Drive, MC 0828, La Jolla, CA 92093-0828, USA
chchambers@...
Selective serotonin reuptake inhibitors and congenital malformations
The small risk of harm must be balanced against risk of suboptimalor no treatment
The first 150 words of the full text of this article appear below.
Major depressive disorder in women is most common during theirchildbearing years, and about 13% of women in the United Stateshave taken an antidepressant drug during pregnancy.1 2 In thepast 20 years, selective serotonin reuptake inhibitors (SSRIs)have become a mainstay of treatment in women with major depressivedisorder; however, concerns persist about safety for the developingfetus. This is counterbalanced by equally compelling concernsabout the consequences of undertreatment for mother and child.3
In the linked population based cohort study from Denmark (doi:10.1136/bmj.b3569),Pedersen and colleagues confirm a previously reported doublingof risk for septal heart defects after early exposure in pregnancyto SSRIs (odds ratio 1.99, 95% confidence interval 1.12 to 3.53).4However, in contrast to previous studies, redemptions of prescriptionsfor citalopram and sertraline, but not paroxetine or fluoxetine,were significantly associated with this group of heart defects.56 7 8 Furthermore, unlike two previous large case-control . . . [Full text of this article]
Christina Chambers, associate professor
1 Division of Dysmorphology and Teratology, Departments of Pediatrics and Family and Preventive Medicine, School of Medicine, University of California San Diego, 9500 Gilman Drive, MC 0828, La Jolla, CA 92093-0828, USA
chchambers@...
Anti-depressants pregnancy 'risk' - source BBC
Anti-depressants pregnancy 'risk'
Medical treatment must balance the health of the mother with potential adverse effects to the developing baby
http://news.bbc.co.uk/1/hi/health/8273350.stm
Children born to women taking anti-depressants in early pregnancy have a small but important increase in heart defects, researchers say.
The study published in the British Medical Journal says depression affects up to 20% of pregnant women.
Exposure to anti-depressants in the womb caused problems in less than 1% of children.
The authors say the overall risk is very low and women should speak to doctors before stopping their drugs.
Selective serotonin re-uptake inhibitors (SSRIs) are medicines commonly used for the treatment of depression .
In 2005, the US Food and Drug Administration issued a warning about the SSRI paroxetine because of an increase in birth defects if it was taken during pregnancy.
Septal heart defects
This study looked at whether there was an association between SSRIs taken in the first trimester of pregnancy and malformations in over 400,000 children born in Denmark between 1996 and 2003.
Maternal age and smoking were taken into account.
The defects found are known as septal heart defects where there is a problem with the wall that divides the left side of the heart from the right side.
The researchers from Aarhus University in Denmark said these defects were 0.4% more prevalent in children of women who redeemed a prescription for an SSRI in the first trimester of pregnancy.
Two SSRIs, sertraline and citalopram, were associated with the problem.
Two others, paroxetine and fluoxetine, were not.
A four-fold increase in septal heart defects was found if women were taking more than one SSRI.
There were no other malformations associated with taking SSRIs.
newsimg.bbc.co.uk/shared/img/o.gif width=5 height=1> newsimg.bbc.co.uk/nol/shared/img/v3/start_quote_rb.gif width=24 height=13> The benefits to the mother of taking SSRIs during pregnancy needs to be weighed up against the small increase in risk to the foetus
Cathy Ross, of the British Heart Foundation
The researchers say the absolute differences in heart defects were low.
Septal heart defects occurred in 2,315 (0.5%) of unexposed children, 12 (0.9%) of SSRI exposed children and 4 (2.1%) of children exposed to more than one type of SSRI.
They estimate that one child for every 246 children exposed was likely to suffer a heart defect.
Lars Henning Pedersen, who led the research, said: "Treatment of depression during pregnancy balances the risk of the medicine with that of the depression, and we investigated only a part of the information needed to make evidence based decisions.
"Even if SSRI use is causally related to septal heart defects, these heart defects might not necessarily require treatment and some might resolve spontaneously."
Professor Basky Thilaganathan, of the Royal College of Obestetrics and Gynaecology, said it was important to remember that many women who suffered depression could be treated without resorting to drugs.
He said: "All hospitals now have a dedicated doctor or liaison officer for women suffering psychiatric symptoms in pregnancy.
"This study shows a less than one in a 100 chance of getting a baby with a defect in the heart."
Cathy Ross, cardiac nurse at the British Heart Foundation (BHF), said: "Depression can be a debilitating condition.
"The benefits to the mother of taking SSRIs during pregnancy needs to be weighed up against the small increase in risk to the foetus."
Medical treatment must balance the health of the mother with potential adverse effects to the developing baby
http://news.bbc.co.uk/1/hi/health/8273350.stm
Children born to women taking anti-depressants in early pregnancy have a small but important increase in heart defects, researchers say.
The study published in the British Medical Journal says depression affects up to 20% of pregnant women.
Exposure to anti-depressants in the womb caused problems in less than 1% of children.
The authors say the overall risk is very low and women should speak to doctors before stopping their drugs.
Selective serotonin re-uptake inhibitors (SSRIs) are medicines commonly used for the treatment of depression .
In 2005, the US Food and Drug Administration issued a warning about the SSRI paroxetine because of an increase in birth defects if it was taken during pregnancy.
Septal heart defects
This study looked at whether there was an association between SSRIs taken in the first trimester of pregnancy and malformations in over 400,000 children born in Denmark between 1996 and 2003.
Maternal age and smoking were taken into account.
The defects found are known as septal heart defects where there is a problem with the wall that divides the left side of the heart from the right side.
The researchers from Aarhus University in Denmark said these defects were 0.4% more prevalent in children of women who redeemed a prescription for an SSRI in the first trimester of pregnancy.
Two SSRIs, sertraline and citalopram, were associated with the problem.
Two others, paroxetine and fluoxetine, were not.
A four-fold increase in septal heart defects was found if women were taking more than one SSRI.
There were no other malformations associated with taking SSRIs.
newsimg.bbc.co.uk/shared/img/o.gif width=5 height=1> newsimg.bbc.co.uk/nol/shared/img/v3/start_quote_rb.gif width=24 height=13> The benefits to the mother of taking SSRIs during pregnancy needs to be weighed up against the small increase in risk to the foetus
Cathy Ross, of the British Heart Foundation
The researchers say the absolute differences in heart defects were low.
Septal heart defects occurred in 2,315 (0.5%) of unexposed children, 12 (0.9%) of SSRI exposed children and 4 (2.1%) of children exposed to more than one type of SSRI.
They estimate that one child for every 246 children exposed was likely to suffer a heart defect.
Lars Henning Pedersen, who led the research, said: "Treatment of depression during pregnancy balances the risk of the medicine with that of the depression, and we investigated only a part of the information needed to make evidence based decisions.
"Even if SSRI use is causally related to septal heart defects, these heart defects might not necessarily require treatment and some might resolve spontaneously."
Professor Basky Thilaganathan, of the Royal College of Obestetrics and Gynaecology, said it was important to remember that many women who suffered depression could be treated without resorting to drugs.
He said: "All hospitals now have a dedicated doctor or liaison officer for women suffering psychiatric symptoms in pregnancy.
"This study shows a less than one in a 100 chance of getting a baby with a defect in the heart."
Cathy Ross, cardiac nurse at the British Heart Foundation (BHF), said: "Depression can be a debilitating condition.
"The benefits to the mother of taking SSRIs during pregnancy needs to be weighed up against the small increase in risk to the foetus."
SSRI & congenital malformations: population based study. published BMJ
Published 23 September 2009, doi:10.1136/bmj.b3569
Cite this as: BMJ 2009;339:b3569
Research
http://www.bmj.com/cgi/content/abstr.../sep23_1/b3569
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
Lars Henning Pedersen, research assistant, visiting scholar 1,2, Tine Brink Henriksen, consultant3, Mogens Vestergaard, general practitioner and associate professor4, Jørn Olsen, professor and chair2, Bodil Hammer Bech, associate professor1
1 Department of Epidemiology, Institute of Public Health, Aarhus University, Bartolin Allé 2, DK-8000 Aarhus, Denmark, 2 UCLA School of Public Health, Department of Epidemiology, 650 Charles E Young Drive South, Los Angeles, CA 90095-1772, USA, 3 Department of Paediatrics, Aarhus University Hospital, DK-8200 Aarhus, Denmark, 4 Department of General Practice, Institute of Public Health, Aarhus University, Bartolin Allé 2, DK-8000 Aarhus, Denmark
Correspondence to: Lars Henning Pedersen, Department of Epidemiology, Institute of Public Health, Aarhus University, Bartolins Allé 2, 8000 Aarhus C, Denmark LHP@...
Objective To investigate any association between selective serotonin reuptake inhibitors (SSRIs) taken during pregnancy and congenital major malformations.
Design Population based cohort study.
Participants 493 113 children born in Denmark, 1996-2003.
Main outcome measure Major malformations categorised according to Eurocat (European Surveillance of Congenital Anomalies) with additional diagnostic grouping of heart defects. Nationwide registers on medical redemptions (filled prescriptions), delivery, and hospital diagnosis provided information on mothers and newborns. Follow-up data available to December 2005.
Results Redemptions for SSRIs were not associated with major malformations overall but were associated with septal heart defects (odds ratio 1.99, 95% confidence interval 1.13 to 3.53). For individual SSRIs, the odds ratio for septal heart defects was 3.25 (1.21 to 8.75) for sertraline, 2.52 (1.04 to 6.10) for citalopram, and 1.34 (0.33 to 5.41) for fluoxetine. Redemptions for more than one type of SSRI were associated with septal heart defects (4.70, 1.74 to 12.7)). The absolute increase in the prevalence of malformations was lowfor example, the prevalence of septal heart defects was 0.5% (2315/493 113) among unexposed children, 0.9% (12/1370) among children whose mothers were prescribed any SSRI, and 2.1% (4/193) among children whose mothers were prescribed more than one type of SSRI.
Conclusion There is an increased prevalence of septal heart defects among children whose mothers were prescribed an SSRI in early pregnancy, particularly sertraline and citalopram. The largest association was found for children of women who redeemed prescriptions for more than one type of SSRI.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
Cite this as: BMJ 2009;339:b3569
Research
http://www.bmj.com/cgi/content/abstr.../sep23_1/b3569
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
Lars Henning Pedersen, research assistant, visiting scholar 1,2, Tine Brink Henriksen, consultant3, Mogens Vestergaard, general practitioner and associate professor4, Jørn Olsen, professor and chair2, Bodil Hammer Bech, associate professor1
1 Department of Epidemiology, Institute of Public Health, Aarhus University, Bartolin Allé 2, DK-8000 Aarhus, Denmark, 2 UCLA School of Public Health, Department of Epidemiology, 650 Charles E Young Drive South, Los Angeles, CA 90095-1772, USA, 3 Department of Paediatrics, Aarhus University Hospital, DK-8200 Aarhus, Denmark, 4 Department of General Practice, Institute of Public Health, Aarhus University, Bartolin Allé 2, DK-8000 Aarhus, Denmark
Correspondence to: Lars Henning Pedersen, Department of Epidemiology, Institute of Public Health, Aarhus University, Bartolins Allé 2, 8000 Aarhus C, Denmark LHP@...
Objective To investigate any association between selective serotonin reuptake inhibitors (SSRIs) taken during pregnancy and congenital major malformations.
Design Population based cohort study.
Participants 493 113 children born in Denmark, 1996-2003.
Main outcome measure Major malformations categorised according to Eurocat (European Surveillance of Congenital Anomalies) with additional diagnostic grouping of heart defects. Nationwide registers on medical redemptions (filled prescriptions), delivery, and hospital diagnosis provided information on mothers and newborns. Follow-up data available to December 2005.
Results Redemptions for SSRIs were not associated with major malformations overall but were associated with septal heart defects (odds ratio 1.99, 95% confidence interval 1.13 to 3.53). For individual SSRIs, the odds ratio for septal heart defects was 3.25 (1.21 to 8.75) for sertraline, 2.52 (1.04 to 6.10) for citalopram, and 1.34 (0.33 to 5.41) for fluoxetine. Redemptions for more than one type of SSRI were associated with septal heart defects (4.70, 1.74 to 12.7)). The absolute increase in the prevalence of malformations was lowfor example, the prevalence of septal heart defects was 0.5% (2315/493 113) among unexposed children, 0.9% (12/1370) among children whose mothers were prescribed any SSRI, and 2.1% (4/193) among children whose mothers were prescribed more than one type of SSRI.
Conclusion There is an increased prevalence of septal heart defects among children whose mothers were prescribed an SSRI in early pregnancy, particularly sertraline and citalopram. The largest association was found for children of women who redeemed prescriptions for more than one type of SSRI.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
Seroxat consumption in total collapse - this blog asks Hugh James Solicitors to explain how their so called clients got off?
http://www.ahrp.org/COI/PaxilDeclineUK.pdfThursday, 24 September 2009
**EXCLUSIVE - KILKER v GLAXOSMITHKLINE COURT DOCUMENTS - all hosted by Scientologist Baum Hedlund
LYAM KILKER, a Minor, by MICHELLE M. DAVID, as Next Friend and Individually
VS.
SMITHKLINE BEECHAM CORPORATION d/b/a GLAXOSMITHKLINE
9/15/09 AM: Opening Statements
Plaintiff’s Expert: David Healy, MD FRCPsych, Neuropyschopharmacologist, Professor of Psychiatry, Cardiff University,University Hospital Wales North Wales Department of Psychological Medicine
9/15/09 PM: David Healy, M.D. -- Direct Examination
9/16/09 AM: David Healy, M.D. -- Direct (continued)
9/16/09 PM: David Healy, M.D. -- Direct (continued); Cross Examination
9/17/09 AM: David Healy, M.D. -- Cross (continued); Redirect
9/17/09 PM: David Healy, M.D. -- Recross; Redirect
Plaintiffs Expert: Suzanne Parisian, M.D., former FDA employee
9/18/09 AM: Suzanne Parisian, M.D. -- Direct Examination
9/18/09 PM: Suzanne Parisian, M.D. -- Direct (continued)
Plaintiff’s Expert: Shira Kramer, Ph.D., Epidemiologist
9/21/09 AM: Shira Kramer, Ph.D. -- Direct Examination
9/21/09 PM: Shira Kramer, Ph.D. -- Direct (continued); Cross Examination; Redirect
VS.
SMITHKLINE BEECHAM CORPORATION d/b/a GLAXOSMITHKLINE
9/15/09 AM: Opening Statements
Plaintiff’s Expert: David Healy, MD FRCPsych, Neuropyschopharmacologist, Professor of Psychiatry, Cardiff University,University Hospital Wales North Wales Department of Psychological Medicine
9/15/09 PM: David Healy, M.D. -- Direct Examination
9/16/09 AM: David Healy, M.D. -- Direct (continued)
9/16/09 PM: David Healy, M.D. -- Direct (continued); Cross Examination
9/17/09 AM: David Healy, M.D. -- Cross (continued); Redirect
9/17/09 PM: David Healy, M.D. -- Recross; Redirect
Plaintiffs Expert: Suzanne Parisian, M.D., former FDA employee
9/18/09 AM: Suzanne Parisian, M.D. -- Direct Examination
9/18/09 PM: Suzanne Parisian, M.D. -- Direct (continued)
Plaintiff’s Expert: Shira Kramer, Ph.D., Epidemiologist
9/21/09 AM: Shira Kramer, Ph.D. -- Direct Examination
9/21/09 PM: Shira Kramer, Ph.D. -- Direct (continued); Cross Examination; Redirect
UKsurvivors mssg 48854
--- In uksurvivors@yahoogroups.com, "bob_fid2000"
>
> Judging by the goader's recent 'pro GSK' posts, one would assume that he is desperate for the current Paxil trial to be doomed to failure. Pretty sad considering all those babies that have been born with heart defects as a result of GSK's drug.
>
http://groups.yahoo.com/group/uksurvivors/message/48854
I will start by saying what I have repeatedly said when posting on this and other lists - I have no problem with anyone taking legal action and have never spoken out against the litigation.
It would appear from this post that although concern is expressed about "babies born with heart defects" - it's only babies affected by Seroxat / Paxil that seem to matter, when you consider what has already been posted in regard the Efexor heart defect baby deaths!! Now that's pretty sad too.
So what about the babies born with birth defects who's mothers were and are still taking one of the other drugs in the class – mothers blissfully unaware of the risk they are taking? And why is that?
Is it possibly due to the extreme adverse publicity afforded to the one particular drug - Seroxat?
Little things - like the much publicised Panorama Seroxat programs - that the Shelley Jofre's Coventry University Lecture Podcast clearly states were deliberately focused on the one drug – despite the production team and herself knowing the problems with SSRIs were a drug class phenomenon – Panorama actively chose to concentrate only on Seroxat? http://coventryuniversity.podbean.com/2007/11/01/one-woman-a-multinational-and-a-victory-shelley-jofre-panorama/
The publicity procured by the Seroxat litigation Lawyers Hugh James who liaised with Shelley Jofre and Panorama throughout the production of their first Seroxat program?
The publicity purchased by Hugh James and their PR company Good Relations – further generated by a few self seeking politicians like Paul Flynn who took the SSRI issue to parliament but only named Seroxat – and persist on their blogs to still do this - despite them commenting on an article about the SSRI drug class?
The biased and lazy journalism of the media and main stream press who latched onto - because of the Panorama programs and political interest - a quick fix, already sensationalized headline and used the name Seroxat as a marketing tool - despite their articles being about problems with the drug class?
The yellow cards published by MIND for Panorama - aimed at and issued to those taking Seroxat who contacted the show - that were accepted by the MHRA - that have further distorted statistics vital to establish all drug ADR issues?
The now misrepresented Yellow Card reports that NICE and the MHRA rely on and have to work with as available data and statistics, to assess all drugs efficacy and safety?
Here's the result of this publicity
http://tuesday1st.blogspot.com/
Seroxat prescriptions have fallen from 3.7 million in 2001 to 1.6 million in 2008
whilst total prescriptions for the drug class have increased from 14 million in 2001 to 24.3 million in 2008
Exclude Seroxat from the equation and total prescription for the SSSRI, SNRI drug class have risen from 10.3 million in 2001 to a 2008 total of 22.7 million
That's thousands – no - Millions of people who have - and are being denied the right to make an informed choice about treatment with the SSRI, SNRI drug class -
and Millions including unborn babies at risk.
The more recent publicity about birth defects and article by Dr David Healy was centred on the SSRI, SNRI drug class - but Seroxat has still been the most named drug in the media.
The whole contrived and generated Seroxat withdrawal furore has been a self perpetuating roller coaster and it's the patients on ALL drugs in the class that are the victims of it.
At patient level the publicity will have raised awareness of withdrawal problems with Seroxat – this will give rise to expectation, dread, even fear of having problems when coming off it;
A self fulfilling prophecy as this will compound and exaggerate any withdrawal symptoms however slight and make them appear worse; those affected will make more complaints to docs with the accompanying question "is it Seroxat?".
Docs, to a point, are guided by the findings of NICE and the MHRA, but also by their own opinions - probably influenced by the Seroxat publicity;
This will give a false raised awareness of problems with that particular drug and possibly the sense of a need for self protection and damage limitation, because the word litigation has been brought into the equation.
This will have resulted in them listening to and taking patient complaints of ADRs with Seroxat more seriously than patient complaints about other drugs in the class, looking for further serious possible ADRs and more stringent yellow card reporting.
My concern about the possible connection with the SSRI, SNRI drug class and birth defects goes back to before 2003/4, when I spent nearly a year helping one young woman get off Seroxat and alcohol because she wanted to have a second child.
Only to have her contact me in a panic in 2006 when her marriage and she had a wobble, her GP prescribed and she had started taking fluoxetine at the end of her first trimester.
Had her GP said Prozac she would have immediately recognised the drug and known it was an SSRI, although this would have been doubtful with other lesser publicised drugs in the class.
To those not involved with the litigation - this is of special concern with regard more serious side effects and ADRs like birth defects - because the medical profession are not looking for or associating them with the other drugs in the class - neither are patients.
To those involved with the litigation – of special concern is maintaining Seroxats single drug false notoriety to protect the Group, Seroxat Litigation Order: No 68: which shows that the whole litigation is dependant on the very flimsy `Defining Issue' that Seroxat is harder to get off than any other SSRI. http://www.hmcourts-service.gov.uk/cms/150_14671.htm
The litigation has been framed to make Seroxat appear the worse drug in the class which is giving the false impression that the other drugs in the class are safe –
as I said I'm not against anyone taking legal action or the litigation – I am against the harm it's causing millions of other people including Seroxat victims who have – to their cost - been swapped to other drugs in the class.
Tues
http://www.seroxatusergroup.org.UK/Documents/newsletter2.doc
Extract from Seroxat Newsletter-
"BBC Panorama is planning to broadcast a follow up to the `Secrets of Seroxat' documentary in May. Many of you who contacted the programme will have been asked by the producer to fill in a special version of the Yellow Card designed for Panorama by MIND. The Yellow Card system is used by GPs to report drug safety issues to the Medicine's Control Agency. If your GP has not already filled in a Yellow Card about Seroxat, please ask them to do so. see full document here"
Tuesday1st UK: SSRI / SNRI Antidepressant Statistical Politics.
http://tuesday1st.blogspot.com
>
> Judging by the goader's recent 'pro GSK' posts, one would assume that he is desperate for the current Paxil trial to be doomed to failure. Pretty sad considering all those babies that have been born with heart defects as a result of GSK's drug.
>
http://groups.yahoo.com/group/uksurvivors/message/48854
I will start by saying what I have repeatedly said when posting on this and other lists - I have no problem with anyone taking legal action and have never spoken out against the litigation.
It would appear from this post that although concern is expressed about "babies born with heart defects" - it's only babies affected by Seroxat / Paxil that seem to matter, when you consider what has already been posted in regard the Efexor heart defect baby deaths!! Now that's pretty sad too.
So what about the babies born with birth defects who's mothers were and are still taking one of the other drugs in the class – mothers blissfully unaware of the risk they are taking? And why is that?
Is it possibly due to the extreme adverse publicity afforded to the one particular drug - Seroxat?
Little things - like the much publicised Panorama Seroxat programs - that the Shelley Jofre's Coventry University Lecture Podcast clearly states were deliberately focused on the one drug – despite the production team and herself knowing the problems with SSRIs were a drug class phenomenon – Panorama actively chose to concentrate only on Seroxat? http://coventryuniversity.podbean.com/2007/11/01/one-woman-a-multinational-and-a-victory-shelley-jofre-panorama/
The publicity procured by the Seroxat litigation Lawyers Hugh James who liaised with Shelley Jofre and Panorama throughout the production of their first Seroxat program?
The publicity purchased by Hugh James and their PR company Good Relations – further generated by a few self seeking politicians like Paul Flynn who took the SSRI issue to parliament but only named Seroxat – and persist on their blogs to still do this - despite them commenting on an article about the SSRI drug class?
The biased and lazy journalism of the media and main stream press who latched onto - because of the Panorama programs and political interest - a quick fix, already sensationalized headline and used the name Seroxat as a marketing tool - despite their articles being about problems with the drug class?
The yellow cards published by MIND for Panorama - aimed at and issued to those taking Seroxat who contacted the show - that were accepted by the MHRA - that have further distorted statistics vital to establish all drug ADR issues?
The now misrepresented Yellow Card reports that NICE and the MHRA rely on and have to work with as available data and statistics, to assess all drugs efficacy and safety?
Here's the result of this publicity
http://tuesday1st.blogspot.com/
Seroxat prescriptions have fallen from 3.7 million in 2001 to 1.6 million in 2008
whilst total prescriptions for the drug class have increased from 14 million in 2001 to 24.3 million in 2008
Exclude Seroxat from the equation and total prescription for the SSSRI, SNRI drug class have risen from 10.3 million in 2001 to a 2008 total of 22.7 million
That's thousands – no - Millions of people who have - and are being denied the right to make an informed choice about treatment with the SSRI, SNRI drug class -
and Millions including unborn babies at risk.
The more recent publicity about birth defects and article by Dr David Healy was centred on the SSRI, SNRI drug class - but Seroxat has still been the most named drug in the media.
The whole contrived and generated Seroxat withdrawal furore has been a self perpetuating roller coaster and it's the patients on ALL drugs in the class that are the victims of it.
At patient level the publicity will have raised awareness of withdrawal problems with Seroxat – this will give rise to expectation, dread, even fear of having problems when coming off it;
A self fulfilling prophecy as this will compound and exaggerate any withdrawal symptoms however slight and make them appear worse; those affected will make more complaints to docs with the accompanying question "is it Seroxat?".
Docs, to a point, are guided by the findings of NICE and the MHRA, but also by their own opinions - probably influenced by the Seroxat publicity;
This will give a false raised awareness of problems with that particular drug and possibly the sense of a need for self protection and damage limitation, because the word litigation has been brought into the equation.
This will have resulted in them listening to and taking patient complaints of ADRs with Seroxat more seriously than patient complaints about other drugs in the class, looking for further serious possible ADRs and more stringent yellow card reporting.
My concern about the possible connection with the SSRI, SNRI drug class and birth defects goes back to before 2003/4, when I spent nearly a year helping one young woman get off Seroxat and alcohol because she wanted to have a second child.
Only to have her contact me in a panic in 2006 when her marriage and she had a wobble, her GP prescribed and she had started taking fluoxetine at the end of her first trimester.
Had her GP said Prozac she would have immediately recognised the drug and known it was an SSRI, although this would have been doubtful with other lesser publicised drugs in the class.
To those not involved with the litigation - this is of special concern with regard more serious side effects and ADRs like birth defects - because the medical profession are not looking for or associating them with the other drugs in the class - neither are patients.
To those involved with the litigation – of special concern is maintaining Seroxats single drug false notoriety to protect the Group, Seroxat Litigation Order: No 68: which shows that the whole litigation is dependant on the very flimsy `Defining Issue' that Seroxat is harder to get off than any other SSRI. http://www.hmcourts-service.gov.uk/cms/150_14671.htm
The litigation has been framed to make Seroxat appear the worse drug in the class which is giving the false impression that the other drugs in the class are safe –
as I said I'm not against anyone taking legal action or the litigation – I am against the harm it's causing millions of other people including Seroxat victims who have – to their cost - been swapped to other drugs in the class.
Tues
http://www.seroxatusergroup.org.UK/Documents/newsletter2.doc
Extract from Seroxat Newsletter-
"BBC Panorama is planning to broadcast a follow up to the `Secrets of Seroxat' documentary in May. Many of you who contacted the programme will have been asked by the producer to fill in a special version of the Yellow Card designed for Panorama by MIND. The Yellow Card system is used by GPs to report drug safety issues to the Medicine's Control Agency. If your GP has not already filled in a Yellow Card about Seroxat, please ask them to do so. see full document here"
Tuesday1st UK: SSRI / SNRI Antidepressant Statistical Politics.
http://tuesday1st.blogspot.com
Seroxat group drops 95% of claimed membership as Mark Harvey / Hugh James confirms only 500 claim against GSK
Advertisement from today's Guardian Newspaper, in the G2 television supplement section a couple pages before the TV listings on the left hand side.
UK Blogger's please feel free to disseminate.
(previously published) Director of MHRA confirms that Bob Fiddaman introduced Scientology journalist Janne Larsson into the PPE consultation process
From: Gregor, Simon
Date: 18/05/2009 14:07:37
To: Jeremy Bryce
Subject: RE: re - Janne Larsson
Dear Mr Bryce
Thank you for your email.
The MHRA has recently published a patient and public engagement strategy, and as part of this we are taking steps to engage more with patients and consumers who have an interest in our work. You can find the strategy on our website at http://www.mhra.gov.uk/home/groups/comms-sp/documents/publication/con041519.pdf.
I and some of my colleagues are, as part of this initiative, making some initial contacts with a number of organisations and individuals who have an interest in what we do, and it is in that context that I met with Mr Fiddaman. The purpose of these meetings is to discuss our patient and public engagement strategy, get views on it and in particular on any challenges we may face. As part of my discussion with Mr Fiddaman, he did indeed suggest a number of individuals with whom I might meet (including Mr Larsson), and I agreed to open up a dialogue with them if they were also willing to do so. The MHRA is aiming to open up similar interactions with other individuals and patient groups as well, outside the field of SSRIs.
In terms of timing, this is a medium-long term strategy - you will see that the current document covers a two-year time span, and our aim is to publish a second strategy following on from that. Meetings will therefore take place over a period of time, and as yet I do not have dates or details for any of the meetings which Mr Fiddaman suggested.
As far as the scientology issue is concerned, I did not enquire as to the religious background of any of those people whom Mr Fiddaman suggested. The MHRA has no policy in this area. We will engage with individual stakeholders regardless of religious interest, expressed or otherwise.
I hope this answers your questions. On a more general note, I know that you are someone who has from time-to-time had contact with the Agency, and you may well have views yourself on the challenges for us in engaging with patients and the public. If, having read the strategy, there are any matters you would like to discuss with me, please let me know, and I would be happy to talk to you about them.
Best wishes
Simon
Simon Gregor
Director of Communications, MHRA
Tel 020 7084 3540
Date: 18/05/2009 14:07:37
To: Jeremy Bryce
Subject: RE: re - Janne Larsson
Dear Mr Bryce
Thank you for your email.
The MHRA has recently published a patient and public engagement strategy, and as part of this we are taking steps to engage more with patients and consumers who have an interest in our work. You can find the strategy on our website at http://www.mhra.gov.uk/home/groups/comms-sp/documents/publication/con041519.pdf.
I and some of my colleagues are, as part of this initiative, making some initial contacts with a number of organisations and individuals who have an interest in what we do, and it is in that context that I met with Mr Fiddaman. The purpose of these meetings is to discuss our patient and public engagement strategy, get views on it and in particular on any challenges we may face. As part of my discussion with Mr Fiddaman, he did indeed suggest a number of individuals with whom I might meet (including Mr Larsson), and I agreed to open up a dialogue with them if they were also willing to do so. The MHRA is aiming to open up similar interactions with other individuals and patient groups as well, outside the field of SSRIs.
In terms of timing, this is a medium-long term strategy - you will see that the current document covers a two-year time span, and our aim is to publish a second strategy following on from that. Meetings will therefore take place over a period of time, and as yet I do not have dates or details for any of the meetings which Mr Fiddaman suggested.
As far as the scientology issue is concerned, I did not enquire as to the religious background of any of those people whom Mr Fiddaman suggested. The MHRA has no policy in this area. We will engage with individual stakeholders regardless of religious interest, expressed or otherwise.
I hope this answers your questions. On a more general note, I know that you are someone who has from time-to-time had contact with the Agency, and you may well have views yourself on the challenges for us in engaging with patients and the public. If, having read the strategy, there are any matters you would like to discuss with me, please let me know, and I would be happy to talk to you about them.
Best wishes
Simon
Simon Gregor
Director of Communications, MHRA
Tel 020 7084 3540
Scientology journalist Janne Larsson links to Bob Fiddaman of continued interest to Eli Lilly
Host Name us_proxy_indy.xh1.lilly.com
IP Address 40.0.40.10
ISP ELI LILLY AND COMPANY
Domain LILLY.COM
City INDIANAPOLIS
Region INDIANA
Country UNITED STATES
Returning Visits 5
Date Time WebPage
September 24, 2009 1:35:46 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://bobfiddaman.blogspot.com/
Referrer link not available
September 24, 2009 1:16:44 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Eli Lilly interested in how Fiddaman tried to infiltrate Scientology journalist Janne Larsson into the MHRA
http://bobfiddaman.blogspot.com/2009/09/eli-lilly-interested-in-how-fiddaman.html
Referrer link not available
September 23, 2009 1:33:07 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
Referrer link not available
September 23, 2009 12:57:01 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:56:42 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: I have given Simon names of advocates whom I think have something useful to say. - including Janne Larsson [Investigative Writer]
http://bobfiddaman.blogspot.com/2009/05/i-put-forward-following-to-simon.html
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
September 23, 2009 12:55:50 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:55:05 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:53:49 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
IP Address 40.0.40.10
ISP ELI LILLY AND COMPANY
Domain LILLY.COM
City INDIANAPOLIS
Region INDIANA
Country UNITED STATES
Returning Visits 5
Date Time WebPage
September 24, 2009 1:35:46 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://bobfiddaman.blogspot.com/
Referrer link not available
September 24, 2009 1:16:44 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Eli Lilly interested in how Fiddaman tried to infiltrate Scientology journalist Janne Larsson into the MHRA
http://bobfiddaman.blogspot.com/2009/09/eli-lilly-interested-in-how-fiddaman.html
Referrer link not available
September 23, 2009 1:33:07 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
Referrer link not available
September 23, 2009 12:57:01 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:56:42 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: I have given Simon names of advocates whom I think have something useful to say. - including Janne Larsson [Investigative Writer]
http://bobfiddaman.blogspot.com/2009/05/i-put-forward-following-to-simon.html
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
September 23, 2009 12:55:50 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:55:05 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:53:49 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
So clearly the fact that evidence is "blatent hearsay" is irrelevant to Scientology stooge Bob Fiddaman
Re: Paxil evidence was blatent hearsay
http://groups.yahoo.com/group/uksurvivors/message/48831
Judging by the goader's recent 'pro GSK' posts, one would assume that he is
desperate for the current Paxil trial to be doomed to failure. Pretty sad
considering all those babies that have been born with heart defects as a result
of GSK's drug.
Fid
http://groups.yahoo.com/group/uksurvivors/message/48831
Judging by the goader's recent 'pro GSK' posts, one would assume that he is
desperate for the current Paxil trial to be doomed to failure. Pretty sad
considering all those babies that have been born with heart defects as a result
of GSK's drug.
Fid
uksurvivors : Message: Re: Paxil evidence was blatent hearsay
uksurvivors : Message: Re: Paxil evidence was blatent hearsay: Re: Paxil evidence was blatent hearsay
Judging by the goader's recent 'pro GSK' posts, one would assume that he is
desperate for the current Paxil trial to be doomed to failure. Pretty sad
considering all those babies that have been born with heart defects as a result
of GSK's drug.
Fid
--- In uksurvivors@yahoogroups.com, Cynders Cardell
>
> You know for some-one who complains (very) bitterly about discussions being
only about Seroxat/Paxil/paroxetine ,you dont half go on about it !!!!
> You dredge up posts from yonks ago round and round ,like a frustrated
groundhog day gopher .
> No-one else needs to post about the subject !We'll leave it all to you .
> Going out for some very wanted fresh air!
> Bitter and twisted does not make for good discussions ,whereas dogged
obsession is just plain scary.
>
>
>
>
> From Cynders in Cornish heaven. :-0)
>
>
>
>
>
Judging by the goader's recent 'pro GSK' posts, one would assume that he is
desperate for the current Paxil trial to be doomed to failure. Pretty sad
considering all those babies that have been born with heart defects as a result
of GSK's drug.
Fid
--- In uksurvivors@yahoogroups.com, Cynders Cardell
>
> You know for some-one who complains (very) bitterly about discussions being
only about Seroxat/Paxil/paroxetine ,you dont half go on about it !!!!
> You dredge up posts from yonks ago round and round ,like a frustrated
groundhog day gopher .
> No-one else needs to post about the subject !We'll leave it all to you .
> Going out for some very wanted fresh air!
> Bitter and twisted does not make for good discussions ,whereas dogged
obsession is just plain scary.
>
>
>
>
> From Cynders in Cornish heaven. :-0)
>
>
>
>
>
so who says Paxil / Seroxat evidence is blaent hearsay - check out the source
http://groups.yahoo.com/group/uksurvivors/message/48838
source -
Beck/Herrmann
JAMES M. BECK is a Counsel resident in the Philadelphia office of Dechert LLP. He is the author of, among other things, Drug and Medical Device Product Liability Handbook (2004) (with Anthony Vale). He can be reached at james.beck@.... MARK HERRMANN is a partner resident in the Chicago office of Jones Day. He is the author of, among other things, The Curmudgeon's Guide to Practicing Law (2006), and Statewide Coordinated Proceedings: State Court Analogues to the Federal MDL Process (2d rev. ed. 2004) (with Geoff Ritts and Katherine Larson). He can be reached at mherrmann@....
http://druganddevicelaw.blogspot.com/2009/09/odd-evidentiary-ruling-in-philadelphia.html
extract -
That evidentiary ruling, assuming Bloomberg accurately reported it, leaves us scratching our heads. It's blatant hearsay, and since the regularity of the statement by the phantom declarant (and the requisite authority) was obviously unproven, it can't plausibly be considered a business record.
That would leave "admission of a party opponent" as the only other ground for letting that in.
But in Pennsylvania, the law is pretty clear that phantom declarant admissions aren't admissible. In Harris v. Toys "R" Us-Penn, Inc., 880 A.2d 1270 (Pa. Super. 2005), a unanimous panel held that the purported "admission" of a phantom employee that he hadn't "put up right" a carton that later fell off a shelf and hit the plaintiff was inadmissible. To establish ..................
source -
Beck/Herrmann
JAMES M. BECK is a Counsel resident in the Philadelphia office of Dechert LLP. He is the author of, among other things, Drug and Medical Device Product Liability Handbook (2004) (with Anthony Vale). He can be reached at james.beck@.... MARK HERRMANN is a partner resident in the Chicago office of Jones Day. He is the author of, among other things, The Curmudgeon's Guide to Practicing Law (2006), and Statewide Coordinated Proceedings: State Court Analogues to the Federal MDL Process (2d rev. ed. 2004) (with Geoff Ritts and Katherine Larson). He can be reached at mherrmann@....
http://druganddevicelaw.blogspot.com/2009/09/odd-evidentiary-ruling-in-philadelphia.html
extract -
That evidentiary ruling, assuming Bloomberg accurately reported it, leaves us scratching our heads. It's blatant hearsay, and since the regularity of the statement by the phantom declarant (and the requisite authority) was obviously unproven, it can't plausibly be considered a business record.
That would leave "admission of a party opponent" as the only other ground for letting that in.
But in Pennsylvania, the law is pretty clear that phantom declarant admissions aren't admissible. In Harris v. Toys "R" Us-Penn, Inc., 880 A.2d 1270 (Pa. Super. 2005), a unanimous panel held that the purported "admission" of a phantom employee that he hadn't "put up right" a carton that later fell off a shelf and hit the plaintiff was inadmissible. To establish ..................
Seroxat / Paxil birth defect litigation evidence was blatent hearsay
Paxil evidence was blatent hearsay
http://groups.yahoo.com/group/uksurvivors/message/48807
According to a Bloomberg report from last Friday, a plaintiff witness who once worked for the defendant was permitted to testify that some unknown person had made a "note in the company's files" that a different birth defect incident (not part of this suit) was "likely linked" to the drug. This phantom declarant testimony was allowed even though the witness giving it admitted that what happened might have been a "mistake" and that the phantom could have "checked the box wrong."
That evidentiary ruling, assuming Bloomberg accurately reported it, leaves us scratching our heads. It's blatant hearsay, and since the regularity of the statement by the phantom declarant (and the requisite authority) was obviously unproven, it can't plausibly be considered a business record.
http://druganddevicelaw.blogspot.com/2009/09/odd-evidentiary-ruling-in-philadelphia.html
http://groups.yahoo.com/group/uksurvivors/message/48807
According to a Bloomberg report from last Friday, a plaintiff witness who once worked for the defendant was permitted to testify that some unknown person had made a "note in the company's files" that a different birth defect incident (not part of this suit) was "likely linked" to the drug. This phantom declarant testimony was allowed even though the witness giving it admitted that what happened might have been a "mistake" and that the phantom could have "checked the box wrong."
That evidentiary ruling, assuming Bloomberg accurately reported it, leaves us scratching our heads. It's blatant hearsay, and since the regularity of the statement by the phantom declarant (and the requisite authority) was obviously unproven, it can't plausibly be considered a business record.
http://druganddevicelaw.blogspot.com/2009/09/odd-evidentiary-ruling-in-philadelphia.html
Wednesday, 23 September 2009
Karishma Jasani read more on Seroxat User Group Newsletter Issue 1
Karishma Jasani. Marlene Hart. Please address all enquiries to. Karishma and ... intrusion to members as possible. E. karishma jasani@hughjames.com ...
www.seroxatusergroup.org.uk/Documents/newsletterissue1.pdf
Seroxat / Paxil birth defect litigation l evidence was blatent hearsay
Paxil evidence was blatent hearsay
According to a Bloomberg report from last Friday, a plaintiff witness who once worked for the defendant was permitted to testify that some unknown person had made a "note in the company's files" that a different birth defect incident (not part of this suit) was "likely linked" to the drug. This phantom declarant testimony was allowed even though the witness giving it admitted that what happened might have been a "mistake" and that the phantom could have "checked the box wrong."
That evidentiary ruling, assuming Bloomberg accurately reported it, leaves us scratching our heads. It's blatant hearsay, and since the regularity of the statement by the phantom declarant (and the requisite authority) was obviously unproven, it can't plausibly be considered a business record.
http://druganddevicelaw.blogspot.com/2009/09/odd-evidentiary-ruling-in-philadelphia.html
According to a Bloomberg report from last Friday, a plaintiff witness who once worked for the defendant was permitted to testify that some unknown person had made a "note in the company's files" that a different birth defect incident (not part of this suit) was "likely linked" to the drug. This phantom declarant testimony was allowed even though the witness giving it admitted that what happened might have been a "mistake" and that the phantom could have "checked the box wrong."
That evidentiary ruling, assuming Bloomberg accurately reported it, leaves us scratching our heads. It's blatant hearsay, and since the regularity of the statement by the phantom declarant (and the requisite authority) was obviously unproven, it can't plausibly be considered a business record.
http://druganddevicelaw.blogspot.com/2009/09/odd-evidentiary-ruling-in-philadelphia.html
Karishma Jasani solicitor in Kennedys' Product Liability Team - checking out Scientology Fiddaman links
Host Name 193.195.181.1
IP Address 193.195.181.1
ISP REBUS IS
Domain DEMON.CO.UK
City LONDON
Region ENGLAND
Country UNITED KINGDOM
Returning Visits
Date Time WebPage
September 23, 2009 1:31:11 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: 11-Jan-2009
http://bobfiddaman.blogspot.com/2009_01_11_archive.html
http://www.google.co.uk/search?hl=en&source=hp&q=karishma jasani&meta=&rlz=1R2AD SA_enGB344&aq=0&oq=karishma jas
IP Address 193.195.181.1
ISP REBUS IS
Domain DEMON.CO.UK
City LONDON
Region ENGLAND
Country UNITED KINGDOM
Returning Visits
Date Time WebPage
September 23, 2009 1:31:11 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: 11-Jan-2009
http://bobfiddaman.blogspot.com/2009_01_11_archive.html
http://www.google.co.uk/search?hl=en&source=hp&q=karishma jasani&meta=&rlz=1R2AD SA_enGB344&aq=0&oq=karishma jas
Eli Lilly interested in how Fiddaman tried to infiltrate Scientology journalist Janne Larsson into the MHRA
Host Name us_proxy_indy.xh1.lilly.com
IP Address 40.0.40.10
ISP ELI LILLY AND COMPANY
Domain LILLY.COM
City INDIANAPOLIS
Region INDIANA
Country UNITED STATES
Returning Visits 0
Date Time WebPage
September 23, 2009 1:33:07 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
Referrer link not available
September 23, 2009 12:57:01 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:56:42 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: I have given Simon names of advocates whom I think have something useful to say. - including Janne Larsson [Investigative Writer]
http://bobfiddaman.blogspot.com/2009/05/i-put-forward-following-to-simon.html
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
September 23, 2009 12:55:50 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:55:05 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:53:49 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.
IP Address 40.0.40.10
ISP ELI LILLY AND COMPANY
Domain LILLY.COM
City INDIANAPOLIS
Region INDIANA
Country UNITED STATES
Returning Visits 0
Date Time WebPage
September 23, 2009 1:33:07 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
Referrer link not available
September 23, 2009 12:57:01 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:56:42 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: I have given Simon names of advocates whom I think have something useful to say. - including Janne Larsson [Investigative Writer]
http://bobfiddaman.blogspot.com/2009/05/i-put-forward-following-to-simon.html
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
September 23, 2009 12:55:50 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:55:05 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.aspx?n=1068027301
September 23, 2009 12:53:49 PM SEROXAT SUFFERERS - STAND UP AND BE COUNTED: perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
http://bobfiddaman.blogspot.com/2009/09/perviously-published-foi-fiddaman.html
http://by109w.bay109.mail.live.com/mail/InboxLight.
"Shaking the tree" - if it's good enough for Baum Hedlund it's good enough for Mark Harvey
Mark Harvey says he is still 'shaking the tree' to see how many people are suffering from the sort of severe withdrawal symptoms afflicting Jenny Stanaway. People are learning of his interest at the rate of about two a week. The most common story he hears is that the drug initially worked, but then the difficulties really started. At present he has 120 people on his books, and he has commenced applications for legal aid
http://209.85.229.132/search?q=cache:6n9tfasHQHcJ:www.guardian.co.uk/society/2002/apr/28/mentalhealth+seroxat+shaking+tree&cd=1&hl=en&ct=clnk
http://209.85.229.132/search?q=cache:6n9tfasHQHcJ:www.guardian.co.uk/society/2002/apr/28/mentalhealth+seroxat+shaking+tree&cd=1&hl=en&ct=clnk
Seroxat Scientology lawyers clearly targeting GSK before they had any clients - one could say the were "shaking the tree"
The firm also has a reputation for breaking new ground in these cases. Baum, Hedlund, Aristei & Goldman (including Gillespie) is currently representing about 200 families whose children were born with defects ranging from congenital heart defects to persistent pulmonary hypertension (PPHN), a life threatening condition that occurs soon after birth. In all the cases, women used Paxil or different antidepressant before and during their pregnancy.
Baum Hedlund initiated its investigation of Paxil-induced birth defects based on information they found in documents GSK produced for the suicide cases. Since then, Baum Hedlund has been joined by several other firms that are jointly litigating the birth defects cases around the country.
http://www.lawyersandsettlements.com/articles/10882/kate-gillespie-interview.html
“What we know is that Paxil breaches the placenta,” says Gillespie. “And what happens when Paxil is introduced,” she says “affects each person differently, depending on how much Mom was taking, and when she started taking the Paxil, and for how long she was taking it.”
Baum Hedlund initiated its investigation of Paxil-induced birth defects based on information they found in documents GSK produced for the suicide cases. Since then, Baum Hedlund has been joined by several other firms that are jointly litigating the birth defects cases around the country.
http://www.lawyersandsettlements.com/articles/10882/kate-gillespie-interview.html
“What we know is that Paxil breaches the placenta,” says Gillespie. “And what happens when Paxil is introduced,” she says “affects each person differently, depending on how much Mom was taking, and when she started taking the Paxil, and for how long she was taking it.”
Kate Gillespie - Scientology lawyer (Baum Hedlund) - looks like these guys make a business out of targeting GSK
She is part of a team of the firm’s litigators focusing on drug injury law, in particular, GlaxoSmithKline’s (GSK), widely used antidepressant, Paxil (paroxetine), which has been connected to suicidal tendencies in both teenagers and adults, and more recently birth defects in newborns.
Tuesday, 22 September 2009
perviously published FOI ? - Fiddaman introduces his Scientology friend Janne Larsson to the MHRA,
From: Jeremy Bryce
Date: 18/05/2009 12:07:50
To: Simon.gregor@mhra.gsi.gov.UK
Subject: re - Janne Larsson
Simon Gregor
Director of Communications
MHRA
Simon.gregor@mhra.gsi.gov.UK
Dear Simon Gregor
I read with interest - http://fiddaman.blogspot.com/2009/05/15th-may-meeting-with-mhra-Birmingham.HTML - that you recently met with a Mr Robert Fiddaman.
I note from Mr Fiddaman's self report of your meeting that he put forward the names of several people to you including a certain - "Janne Larsson "
According to Mr Fiddaman's version of the events (Simon has agreed to meet with these individuals and also added BBC TV's, Shelley Jofre, to the list) - you have undertaken to meet with Larsson.
I would like to draw your attention to - http://www.bmj.com/cgi/content/full/335/7616/370
extract -..." that Professor Gillberg had attended in the autumn of 1999. Shortly afterwards, Janne Larsson, a journalist who writes for the Swedish chapter of the Church of Scientology’s Citizens Commission on Human Rights"
therefore it would appear if the BMJ is to be believed that Janne Larsson is a Scientology Journalist !!
Please advise me if it is now or ever has been MHRA policy to involve the Church of Scientology in the running of its affairs?
Given the comments within the BMJ above do you still plan to meet Janne Larsson ?
On what date & at what venue would this proposed meeting take place?
Is Mr Fiddaman's version of events correct i.e. did you actually give him a commitment to meet Janne Larsson ?
Many thanks in advance
Jeremy Bryce
jeremybryce1953@...
Date: 18/05/2009 12:07:50
To: Simon.gregor@mhra.gsi.gov.UK
Subject: re - Janne Larsson
Simon Gregor
Director of Communications
MHRA
Simon.gregor@mhra.gsi.gov.UK
Dear Simon Gregor
I read with interest - http://fiddaman.blogspot.com/2009/05/15th-may-meeting-with-mhra-Birmingham.HTML - that you recently met with a Mr Robert Fiddaman.
I note from Mr Fiddaman's self report of your meeting that he put forward the names of several people to you including a certain - "Janne Larsson "
According to Mr Fiddaman's version of the events (Simon has agreed to meet with these individuals and also added BBC TV's, Shelley Jofre, to the list) - you have undertaken to meet with Larsson.
I would like to draw your attention to - http://www.bmj.com/cgi/content/full/335/7616/370
extract -..." that Professor Gillberg had attended in the autumn of 1999. Shortly afterwards, Janne Larsson, a journalist who writes for the Swedish chapter of the Church of Scientology’s Citizens Commission on Human Rights"
therefore it would appear if the BMJ is to be believed that Janne Larsson is a Scientology Journalist !!
Please advise me if it is now or ever has been MHRA policy to involve the Church of Scientology in the running of its affairs?
Given the comments within the BMJ above do you still plan to meet Janne Larsson ?
On what date & at what venue would this proposed meeting take place?
Is Mr Fiddaman's version of events correct i.e. did you actually give him a commitment to meet Janne Larsson ?
Many thanks in advance
Jeremy Bryce
jeremybryce1953@...
Fiddaman is an admirer of Scientology journalist Janne Larsson
Janne Larsson is a reporter who investigates psychiatry. I've long admired Janne's tenacity and never say die attitude.Janne has long banged the drum about the dangers of Strattera, an apparent non-st…
Read More »
Read More »
NEW JERSEY,MADRID,NEW DELHI, NORD-TRONDELAG, NORWAY ,SAN FRANCISCO,NEWINGTON, VIRGINIA
Global interest in the Scientology backed Bob Fiddaman blog -
Paxil Seroxat's Graham Aldred who worked with Dr Healy shows - massive decline in Seroxat consumption - without any withdrawal clinics
Parox Hist14.doc GA19/05/04
3
IMR uses the common medication unit called TWS, (Two Weeks Supply), this enables the
medication to be accumulated under one universal label regardless of form or concentration.
Chart 2 was plotted using annual data, rather than quarterly data. It shows that the annual
consumption of paroxetine in all its forms grew by more than 1.15 million units per year for 7
years up to 2001, then it fell by 2.7 M units i.e. 25% from 2001 to 2003. In fact this decline is
much worse if the higher precision quarterly data is used; from the peak at Q4 2001 to Q4
2003 the fall was 36%. Annual totals can disguise higher rates of change defined by the
quarters within the years (frequently exploited in financial marketing.)
Seroxat decline UK - no other SSRI has declined as fast as GSK's Paxil/paroxetine - SO HOW DID THEY GET OFF BOB??
Anonymous Hamburg - watching Bob Fiddaman, Seroxat and Scientology
Anonymous Hamburg - We'll beat them all - Scilons or #Zensursula ...Bob Fiddaman, Seroxat and Scientology · /r/ 2007 Advanced Procedure and Axioms · Bill and Ted most Excellent bashing on LRH ...
anon-hh.ning.com/ -
anon-hh.ning.com/ -
CCHR News Update « Psychiatric News - promotes articles by Bob Fiddaman
CCHR News Update « Psychiatric News: "• OpEdNews, an online news source, ran an article called, “A Chemical Imbalance—The Serotonin Myth” by Robert Fiddaman. The author writes that the “serotonin theory” is a complete myth, exploited by the drug company GlaxoSmithKline (antidepressant manufacturer). According to the article, “[H]ere we have GlaxoSmithKline’s paradox. Claim a drug replaces low levels of serotonin, when it has never been scientifically proven that it does, then once ‘hooked’ on the drug the serotonin myth becomes a reality. The levels one comes accustomed to whilst administering the drug are severely missed when withdrawing from the drug. That is the chemical imbalance. That is the reason why Seroxat [Paxil] is such a big seller. That is the reason why GlaxoSmithKline will never publicly admit Seroxat is the cause and not the cure for a chemical imbalance of serotonin in the brain.”
http://www.opednews.com/articles/opedne_r obert_f_070930_a_chemical_imbalance.htm"
http://www.opednews.com/articles/opedne_r obert_f_070930_a_chemical_imbalance.htm"
Scientology sponsors Fiddaman Seroxat Blog
Why did the BBC allow Panorama to be led by the nose by Mark Harvey / Hugh James - "We were talking to the lawyer the whole way through production"
2.30 in Jofre says - " read a little bit in news paper about patients complaints" year 2000 about " Seroxat difficult to withdraw from" .. Jofre found it intriguing Jofre had only just started working on Panorama at that stage3.30 in " Jofre calls SSRI's "SELECTIVE Serotonin Reuptake Inhibitors"4.14 Jofre knew little of how the pharmcutical industry worked4 .30 in Ed says - lets look at antidepressant story4 45 Jofre says although problems with whole class of antidepressants we (bbc) decided to concentrate on SeroxatWhy we narrowed down on Seroxat1 because it was made by GSK2 all the drugs in class cause suicidal thinking on dose change3 Seroxat had a unique problem of withdrawal BECAUSE IT WAS LONGER ACTING ... we decided to focus research into this drug 6.00 in - 40 min Panorama film took Shelley Jofre 8 months to make6.10 in - It's not something you do lightly WE WERE TAKING ON the worlds second largest drug company7.30 We were talking to the lawyer the whole way through production9.30 in - Jofre says "we took a punt" on Dr David Healy
Seroxat video - BBC Panorama Shelley Jofre with Scientology linked lawyer Karen Barth Menzies
http://www.veoh.com/collection/AgriculturalNews/watch/v251729w7zYxt2H
Watch Seroxat in News | View More Free Videos Online at Veoh.com
Watch Seroxat in News | View More Free Videos Online at Veoh.com
This blog asks the Guardian Newspaper - where the withdrawal clinics Scientology Lawyers Baum Hedlund promised?
Drug giant faces huge lawsuit Society guardian.co.uk: "'We have had a heck of a response,' said Skip Murgatroyd, the attorney from Baum, Hedlund, Aristei, Guilford and Schiavo, leading the case. 'It is unprecedented for us. Some of these people are in such bad shape that they can't get off the drug without professional help. Some have been on it for 10 years.
'We're going to ask GlaxoSmithKline to set up centres all over the US to help them.' Hundreds of thousands are believed to be suffering."
http://www.guardian.co.uk/society/2001/sep/06/mentalhealth
'We're going to ask GlaxoSmithKline to set up centres all over the US to help them.' Hundreds of thousands are believed to be suffering."
http://www.guardian.co.uk/society/2001/sep/06/mentalhealth
Florida USA - watching Bob Fiddaman links to Scientology
ISP VERIZON INTERNET SERVICES INC
Domain VERIZON.NET
City NEW PORT RICHEY
Region FLORIDA
Country UNITED STATES
Returning Visits
Date Time WebPage
September 22, 2009 4:50:45 AM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://bobfiddaman.blogspot.com/
http://forums.whyweprotest.net/291-scientology-discussion/bob-fiddaman-seroxat-s cientology-53313/
Domain VERIZON.NET
City NEW PORT RICHEY
Region FLORIDA
Country UNITED STATES
Returning Visits
Date Time WebPage
September 22, 2009 4:50:45 AM SEROXAT SUFFERERS - STAND UP AND BE COUNTED
http://bobfiddaman.blogspot.com/
http://forums.whyweprotest.net/291-scientology-discussion/bob-fiddaman-seroxat-s cientology-53313/
Birmingham Anonymous [BrumAnon] - watching Bob Fiddaman blog - Our Next Main Protest is October, in New Street, Birmingham.
Welcome to Birmingham Anonymous [BrumAnon] Our Next Main Protest is October, in New Street, Birmingham.
http://brumanon.co.uk/doku.php
Listen to how the BBC Panorama team fixed it for UK Scientology linked lawyers to target Seroxat
http://coventryuniversity.podbean.com/2007/11/01/one-woman-a-multinational-and-a-victory-shelley-jofre-panorama/
2.30 in Jofre says - ” read a little bit in news paper about patients complaints” year 2000 about ” Seroxat difficult to withdraw from” .. Jofre found it intriguing Jofre had only just started working on Panorama at that stage
3.30 in ” Jofre calls SSRI’s “SELECTIVE Serotonin Reuptake Inhibitors”
4.14 Jofre knew little of how the pharmcutical industry worked
4 .30 in Ed says - lets look at antidepressant story
4 45 Jofre says although problems with whole class of antidepressants we (bbc) decided to concentrate on Seroxat Why we narrowed down on Seroxat 1 because it was made by GSK 2 all the drugs in class cause suicidal thinking on dose change 3 Seroxat had a unique problem of withdrawal BECAUSE IT WAS LONGER ACTING … we decided to focus research into this drug
6.00 in - 40 min Panorama film took Shelley Jofre 8 months to make
6.10 in - It’s not something you do lightly WE WERE TAKING ON the worlds second largest drug company
7.30 We were talking to the lawyer the whole way through production
9.30 in - Jofre says “we took a punt” on Dr David Healy
2.30 in Jofre says - ” read a little bit in news paper about patients complaints” year 2000 about ” Seroxat difficult to withdraw from” .. Jofre found it intriguing Jofre had only just started working on Panorama at that stage
3.30 in ” Jofre calls SSRI’s “SELECTIVE Serotonin Reuptake Inhibitors”
4.14 Jofre knew little of how the pharmcutical industry worked
4 .30 in Ed says - lets look at antidepressant story
4 45 Jofre says although problems with whole class of antidepressants we (bbc) decided to concentrate on Seroxat Why we narrowed down on Seroxat 1 because it was made by GSK 2 all the drugs in class cause suicidal thinking on dose change 3 Seroxat had a unique problem of withdrawal BECAUSE IT WAS LONGER ACTING … we decided to focus research into this drug
6.00 in - 40 min Panorama film took Shelley Jofre 8 months to make
6.10 in - It’s not something you do lightly WE WERE TAKING ON the worlds second largest drug company
7.30 We were talking to the lawyer the whole way through production
9.30 in - Jofre says “we took a punt” on Dr David Healy
Scientology UK Seroxat litigation lawyer Mark Harvey (Hugh James) Cardiff with inspirational George "Skip" Murgatroyd of Baum Hedlund
Mark says 
"Yeah George thanks for showing me how to make a fortune exploiting mental patients"
"Yeah George thanks for showing me how to make a fortune exploiting mental patients"
Subscribe to:
Posts (Atom)